パーフェクトマスター　頚動脈狭窄症

出版社： メジカルビュー社
著者：
発行日： 2017-04-01
分野： 臨床医学：外科  >  脳神経外科学
ISBN： 9784758315579
電子書籍版： 2017-04-01 （第1版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

14,300 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

14,300 円(税込)

購入する

商品紹介

本書は頚動脈狭窄症の診断・治療に携わる医師が，内科治療，CEA，CASのいずれにも偏らない包括的な必須知識を学べる書籍となっている。

目次

  • パーフェクトマスター　頚動脈狭窄症

    ―目次―

    1．頚動脈狭窄症の必須知識
    2．内科的治療
    3．外科的治療(1)：頚動脈内膜剥離術（CEA）
    4．外科的治療(2)：頚動脈ステント留置術（CAS）
    5．外科的治療(3)：頚動脈狭窄症と複合血管治療
    6．わたしの治療戦略
    7．頚動脈狭窄症のガイドライン・治療指針

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

I 頚動脈狭窄症の必須知識

P.11 掲載の参考文献
1) 荒木信夫, 小林祥泰. 病型・年代別頻度. 脳卒中データバンク 2015, 中山書店, 東京, 2015, p18-9.
 
2) 山口修平, 小林祥泰. 脳卒中データバンクにおける虚血性脳卒中病型別頻度の経年的推移. 脳卒中データバンク 2015, 中山書店, 東京, 2015, p52-3.
 
3) 日本脳卒中学会脳卒中ガイドライン委員会. 脳卒中治療ガイドライン 2015, 協和企画, 東京, 2015.
 
4) Stary HC, Chandler AB, Glacov S, at al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the committee on vascular lesions of the council on arteriosclerosis, American heart association. Arterioscler Thromb Vasc Biol. 1994 ; 14 : 840-56.
 
5) Stary HC, Chandler AB, Dinsmore RE, at al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the committee on vascular lesions of the council on arteriosclerosis, American heart association. Arterioscler Thromb Vasc Biol. 1995 ; 15 : 1512-31.
 
6) Virmani R, Kolodgie FD, Burke AP, et al. Lessons from sudden coronary death. A comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2000 ; 20 : 1262-75.
 
7) Redgrave JNE, Lovett JK, Gallagher PJ, et al. Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms. The Oxford plaque study. Circulation. 2006 ; 113 : 2320-8.
 
8) Howard DPJ, van Lammeren GW, Rothwell PM, et al. Symptomatic carotid atherosclerotic disease. Correlations between plaque composition and ipsilateral stroke risk. Stroke. 2015 ; 46 : 182-9.
 
9) Bhatt DL, Steg PG, Ohman EM, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006 ; 295 : 180-9.
PubMed
P.20 掲載の参考文献
1) Abbott AL. Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis : results of a systematic review and analysis. Stroke. 2009 ; 40 : e573-83.
PubMed
2) Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999 ; 340 : 115-26.
PubMed
3) 山崎昌子, 内山真一郎, 他. 頚部頚動脈狭窄症の病態生理. Brain Nerve. 2010 ; 62 : 1269-75.
 
4) 日本脳卒中学会 脳卒中ガイドライン委員会編. 3-2 無症候性頚部動脈狭窄・閉塞. 脳卒中治療ガイドライン 2015, 協和企画, 東京, 2015, p223.
 
5) 日本動脈硬化学会編. 動脈硬化性疾患予防ガイドライン 2012, 杏林舎, 東京, 2012, p55-61.
 
6) Shimada T, Toyoda K, et al. Prediction of coronary artery disease in patients undergoing carotid endarterectomy. J Neurosurg. 2005 ; 103 : 593-6.
PubMed
7) 循環器病の診断と治療に関するガイドライン, 2010年度合同研究班報告, 虚血性心疾患に対するバイパスグラフトと手術術式の選択ガイドライン (2011年改訂版), 2011, p36.
 
8) 日本脈管学会編. 下肢閉塞性動脈硬化症の診断・治療指針 II. メディカルトリビューン, 東京, 2007, p13-24.
 
9) 日本透析医学会編. 血液透析患者における心血管合併症の評価と治療に関するガイドライン. 透析会誌. 2011 ; 44 : 353-57.
 
P.30 掲載の参考文献
1) Slovut DP, Olin JW. Fibromuscular dysplasia. N Engl J Med. 2004 ; 350 : 1862-71.
PubMed
2) Osborn AG, Anderson RE. Angiographic spectrum of cervical and intracranial fibromuscular dysplasia. Stroke. 1977 ; 8 : 617-26.
PubMed
3) 循環器病の診断と治療に関するガイドライン (2006-2007年度合同研究班報告) : 血管炎症候群の診療ガイドライン高安動脈炎. Circ J. 2007 ; 72, Suppl IV : 1260-75.
 
4) 松岡秀樹. 本邦の実態 (アンケート調査, 後ろ向き登録研究から) 脳動脈解離診療の手引き. 循環器病研究委託費 18公-5 (SCADS-Japan) 脳動脈解離の病態と治療法の開発. 大阪, 国立循環器病センター 内科脳血管部門, 2009, p8-16.
 
5) CADISS trial investigators, Markus HS, Hayter E, et al. Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS) : a randomised trial. Lancet Neurol. 2015 ; 14 : 361-7.
PubMed
6) 高木誠. 脳動脈解離の診断と治療の手引き. 若年者脳卒中診療の手引き. 循環器病研究委託費 12指-2 若年世代の脳卒中の診断, 治療, 予防戦略に関する全国多施設共同研究. 大阪, 国立循環器病センター, 2003, p85-90.
 
7) 塚原徹也. 脳動脈解離の病理, 症状, 診断, 治療のアウトライン. 脳動脈解離診療の手引き. 循環器病研究委託費 18公-5 (SCADS-Japan) 脳血管解離の病態と治療法の開発. 大阪, 国立循環器病センター 内科脳血管部門, 2009, p1-7.
 
8) 脳卒中学会 脳卒中ガイドライン委員会編. 脳卒中治療ガイドライン 2015, 協和企画, 東京, 2015, p240-1.
 
P.39 掲載の参考文献
1) 林健太郎, 永田泉. 合併症のシステマティック・レビュー-適切なInformed Consentのために-頚動脈内膜剥離術. No Shinkei Geka. 2013 ; 41 : 529-39.
 
2) Agur AMR. The neck. Grant's Atlas of Anatomy 9 th edition, Williams & Wilkins, Baltimore, USA, 1991, p550-81.
 
P.53 掲載の参考文献
1) Padget DH. The development of the cranial arteries in the human embryo. Contrib Embryol. 1948 ; 32 : 205-61.
 
2) McLoughlin MJ, Weisbrod G, Wise DJ, et al. Computed tomography in congenital anomalies of the aortic arch and great vessels. Radiology. 1981 ; 138 : 399-403.
PubMed
3) Hastreiter AR, D'Cruz IA, Cantez T, et al. Right-sided aorta. I. Occurrence of right aortic arch in various types of congenital heart disease. II. Right aortic arch, right descending aorta, and associated anomalies. Br Heart J. 1966 ; 28 : 722-39.
PubMed
4) Shuford WH, Sybers RG, Gordon IJ, et al. Circumflex retroesophageal right aortic simulating mediastinal tumor or dissecting aneurysm. Am J Roentgenol. 1986 ; 146 : 491-96.
PubMed
5) De Garis CF, Black IB, Riemenschneider EA. Patterns of the aortic arch in American white and Negro stocks, with comparative notes on certain other mammals. J Anat. 1933 ; 67 : 599-618.
 
6) Uchino A, Saito N, Okada Y, et al. Variation of the origin of the left common carotid artery diagnosed by CT angiography. Surg Radiol Anat. 2013 ; 35 : 339-42.
PubMed
7) Uchino A, Saito N, Watadani T, et al. Nonbifurcating cervical carotid artery diagnosed by MR angiography. Am J Neuroradiol. 2011 ; 32 : 1119-22.
PubMed
8) Kiyosue H, Mori H, Tanoue S, et al. Non-bifurcating carotid artery coexisting with transverse sinus dural arteriovenous fistula. Neuroradiology. 2009 ; 51 : 697-98.
PubMed
9) Sasaki T, Nagashima H, Oya F, et al. Carotid artery stenging for atherosclerotic stenosis associated with non-bifurcating cervical carotid arter y-case report and embryological considerations-. Neurol Med Chir (Tokyo). 2013 ; 53 : 228-32.
 
10) Layton KF, Kallmes DF, Cloft HJ, et al. Bovine aortic arch variant in humans : clarification of a common misnomer. Am J Neuroradiol. 2006 ; 27 : 1541-42.
PubMed
P.60 掲載の参考文献
1) Wolff T, Guirguis-Blake J, et al. Screening for carotid artery stenosis : an update of the evidence for the U. S. Preventive Services Task Force. Ann Intern Med. 2007 ; 147 : 860-70.
 
2) Wadia NH, Monchton G. Intracranial bruits in health and disease. Brain. 1957 ; 80 : 492-509.
 
3) Heyman A, Wilkinson WE, et al. Risk of stroke in asymptomatic persons with cervical ar terial bruits : a population study in Evans County, Georgia. N Engl J Med. 1980 ; 302 : 838-41.
 
4) Wolf PA, Kannel WB, et al. Asymptomatic carotid bruit and risk of stroke. The Framingham study. JAMA. 1981 ; 245 : 1442-5.
PubMed
5) Ratchford EV, Jin Z, et al. Carotid bruit for detection of hemodynamically significant carotid stenosis : the Northern Manhattan Study. Neurol Res. 2009 ; 31 : 748-52.
PubMed
6) 西丸雄也, 関栄二. Carotid bruitと脳梗塞. 日本臨床. 1993 ; 51 (suppl) : 394-8.
 
7) Sauve JS, Thorpe KE, et al. Can bruits distinguish high-grade from moderate symptomatic carotid stenosis? The North American Symptomatic Carotid Endar terectomy Trial. Ann Intern Med. 1994 ; 120 : 633-7.
 
8) 日本脳卒中学会 脳卒中ガイドライン委員会編. 脳卒中治療ガイドライン 2015, 協和企画, 東京, 2015.
 
9) Baquis GD, Pessin MS, et al. Limb shaking-a carotid TIA. Stroke. 1985 ; 16 : 444-8.
PubMed
10) Yanagihara T, Piepgras DG, et al. Repetitive involuntary movement associated with episodic cerebral ischemia. Ann Neurol. 1985 ; 18 : 244-50.
PubMed
11) Kowacs PA, Troiano AR, et al. Carotid transient ischemic attacks presenting as limb-shaking syndrome : report of two cases. Arq Neuropsiquiatr. 2004 ; 62 : 339-41.
PubMed
12) Muller M, Wessel K, et al. Carotid artery disease in vascular ocular syndromes. J Clin Neuroophthalmol. 1993 ; 13 : 175-80.
PubMed
13) 橋本洋一郎, 木村和美. 網膜中心動脈閉塞症で初発し動脈原性脳塞栓症をきたした内頸動脈高度狭窄の1例. 臨床神経. 1995 ; 35 : 1030-3.
 
14) Kearns TP, Hollenhorst RW. Venous-stasis retinopathy of occlusive disease of the carotid artery. Mayo Clin Proc. 1963 ; 38 : 304-12.
PubMed
15) Kersemakers P, Beintema M, et al. Venous stasis retinopathy unlikely results from internal carotid artery obstruction alone. Cerebrovasc Dis. 1992 ; 2 : 305-7.
 
16) Mangla R, Kolar B, et al. Border zone infarcts : pathophysiologic and imaging characteristics. Radiographics. 2011 ; 31 : 1201-14.
PubMed
17) Yong SW, Bang OY, et al. Internal and cortical border-zone infarction : clinical and diffusion-weighted imaging features. Stroke. 2006 ; 37 : 841-6.
PubMed
18) Caplan LR, van Gijn J, eds. Stroke Syndromes-Third Edition, Cambridge University Press.
 
19) Masuda J, Yutani C, et al. Atheromatous embolism in the brain : a clinicopathologic analysis of 15 autopsy cases. Neurology. 1994 ; 44 : 1231-7.
 
20) Pollanen MS, Deck JH. The mechanism of embolic watershed infarction : experimental studies. Can J Neurol Sci. 1990 ; 17 : 395-8.
PubMed
21) Caplan LR, Hennerici M. Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke. Arch Neurol. 1988 ; 55 : 1475-82.
 
22) Bogousslavsky J, Regli F. Unilateral watershed cerebral infarcts. Neurology. 1986 ; 36 : 373-7.
PubMed
23) 平野照之, 橋本洋一郎. 片麻痺を伴わない全失語を呈した脳血栓症の1例. 臨床神経. 1990 ; 30 : 50-4.
 
24) Giroud M, Fayolle H, et al. Incidence of internal carotid artery dissection in the community of Dijon. J Neurol Neurosurg Psychiatry. 1994 ; 57 : 1443.
 
P.67 掲載の参考文献
1) 日本脳神経超音波学会. 頸部血管超音波検査ガイドライン. Neurosonology. 2006 ; 19 : 49-69.
 
2) 山上宏. 超音波診断. 中原一郎編. パーフェクトマスター脳血管内治療 改訂第2版, メジカルビュー社, 東京, 2014, p65-76.
 
3) 大庭秀樹. 頸動脈の3D・4D超音波検査. 超音波検査技術. 2014 ; 39 : 372-8.
 
4) 日本脳神経超音波学会. 頭蓋内超音波検査ガイドライン. Neurosonology. 2006 ; 19 : 113-31.
Medical*Online
5) Naylor AR, Sillesen H, et al. Clinical and imaging features associated with an increased risk of early and late stroke in patients with asymptomatic carotid disease. Eur J Vasc Endovasc Surg. 2014 ; 48 : 633-40.
 
6) Keunen R, Nijmeijer HW, et al. An observational study of pre-operative transcranial Doppler examinations to predict cerebral hyperperfusion following carotid endarterectomies. Neurol Res. 2001 ; 2 : 593-8.
PubMed
7) Fujimoto S, Toyoda K, et al. Diagnostic impact of transcranial color-coded real-time sonography with echo contrast agents for hyperperfusion syndrome after carotid endarterectomy. Stroke. 2004 ; 35 : 1852-6.
PubMed
8) Iwata T, Mori T, et al. Predictors of hyperper fusion syndrome before and immediately after carotid artery stenting in single-photon emission computed tomography and transcranial color-coded real-time sonography studies. Neurosurgery. 2011 ; 68 : 649-55 ; discussion 655-6.
 
9) Yasaka M, Kimura K, et al. Transoral carotid ultrasonography. Stroke. 1998 ; 29 : 1383-8.
PubMed
10) Clark DJ, Lessio S, et al. Safety and utility of intravascular ultrasound-guided carotid artery stenting. Catheter Cardiovasc Interv. 2004 ; 63 : 355-62.
PubMed
P.73 掲載の参考文献
1) Yoshimura S, Kawasaki M, Yamada K, et al. OCT of human carotid arterial plaques. JACC Cardiovasc Imaging. 2011 : 4 : 432-6.
PubMed
2) Yoshimura S, Kawasaki M, Yamada K, et al. Visualization of internal carotid artery atherosclerotic plaques in symptomatic and asymptomatic patients : a comparison of optical coherence tomography and intravascular ultrasound. AJNR Am J Neuroradiol. 2012 ; 33 : 308-13.
PubMed
3) Kume T, Okura H, Kawamoto T, et al. Assessment of the coronary calcification by optical coherence tomography. EuroIntervention. 2011 ; 6 : 768-72.
PubMed
4) Shindo S, Fujii K, Shirakawa M, et al. Morphologic Features of Carotid Plaque Rupture Assessed by Optical Coherence Tomography. AJNR Am J Neuroradiol. 2015 ; 36 : 21406.
 
P.84 掲載の参考文献
1) Silvennoinen HM, Ikonen S, et al. CT angiographic analysis of carotid artery stenosis : comparison of manual assessment, semiautomatic vessel analysis, and digital subtraction angiography. AJNR Am J Neuroradiol. 2007 ; 28 (1) : 97-103.
PubMed
2) Korn A, Bender B, et al. Grading of carotid artery stenosis in the presence of extensive calcifications : dual-energy CT angiography in comparison with contrast-enhanced MR angiography. Clin Neuroradiol. 2015 ; 25 (1) : 33-40.
PubMed
3) Schroeder S, Kopp AF, et al. Noninvasive detection and evaluation of the atherosclerotic plaque with multislice computed tomography. J Am Coll Cardiol. 2001 ; 37 : 1430-5.
PubMed
4) Mannelli L, Mitsumori LM, et al. Changes in measured size of atherosclerotic plaque calcifications in dual-energy CT of ex vivo carotid endarterectomy specimens : effect of monochromatic keV image reconstructions. Eur Radiol. 2013 ; 23 (2) : 367-74.
PubMed
5) Qiao Y, Etesami M, et al. Identification of intraplaque hemorrhage on MR angiography images : a comparison of contrast-enhanced mask and time-of-flight techniques. AJNR Am J Neuroradiol. 2011 ; 32 (3) : 454-9.
PubMed
6) Platzek I, Sieron D, et al. Carotid Artery Stenosis : Comparison of 3D Time-of-Flight MR Angiography and Contrast-Enhanced MR Angiography at 3 T. Radiol Res Pract. 2014 ; 2014 : 508715. doi : 10.1155/2014/508715. Epub 2014 Mar 23.
 
7) Tartari S, Rizzati R, et al. High-resolution MRI of carotid plaque with a neurovascular coil and contrast-enhanced MR angiography : one-stop shopping for the comprehensive assessment of carotid atherosclerosis. AJR Am J Roentgenol. 2011 ; 196 (5) : 1164-71.
PubMed
8) Demarco JK, Ota H,et al. MR carotid plaque imaging and contrast-enhanced MR angiography identifies lesions associated with recent ipsilateral thromboembolic symptoms : an in vivo study at 3T. AJNR Am J Neuroradiol. 2010 ; 31 (8) : 1395-402.
 
9) Ganguly A, Fieselmann A, et al. Cerebral CT perfusion using an interventional C-arm imaging system : cerebral blood flow measurements. AJNR Am J Neuroradiol. 2011 ; 32 (8) : 1525-31.
PubMed
10) Fieselmann A, Manhart M. C-arm CT Perfusion Imaging in the Interventional Suite. Curr Med Imag Rev. 2013 ; 9 (2) : 96-101.
 
P.89 掲載の参考文献
1) Malek AM, Alper SL, Izumo S. Hemodynamic shear stress and its role in atherosclerosis. JAMA. 1999 ; 282 (21) : 2035-42.
PubMed
2) Guerciotti B, Vergara C, Azzimonti L, et al. Computational study of the fluid-dynamics in carotids before and after endarterectomy. J Biomech. 2015. pii : S0021-9290 (15) 00639-9. doi : 10.1016/j.jbiomech.2015.11.009. [Epub ahead of print]
 
3) Lee SW, Antiga L, Spence JD, et al. Geometry of the carotid bifurcation predicts its exposure to disturbed flow. Stroke. 2008 ; 39 (8) : 2341-7.
PubMed
4) Schirmer CM, Malek AM. Computational fluid dynamic characterization of carotid bifurcation stenosis in patient-based geometries. Brain Behav. 2012 ; 2 (1) : 42-52.
PubMed
P.96 掲載の参考文献
1) Hirooka R, Ogasawara K, et al. Simple assessment of cerebral hemodynamics using single-slab 3D time-of-flight MR angiography in patients with cervical internal carotid artery steno-occlusive diseases : comparison with quantitative perfusion single-photon emission CT. AJNR Am J Neuroradiol. 2009 ; 30 : 559-63.
PubMed
2) Powers WJ, Press GA, et al. The effect of hemodynamically significant carotid artery disease on the hemodynamic status of the cerebral circulation. Ann Intern Med. 1987 ; 106 : 27-34.
PubMed
3) Kuroda S, Houkin K, et al. Long-term prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion : can acetazolamide test predict it? Stroke. 2001 ; 32 : 2110-6.
 
4) JET Study Group. Japanese EC-IC Bypass Trial (JET Study) : 中間解析結果 (第二報). 脳卒中の外科. 2002 ; 30 : 434-7.
 
5) Powers WJ, Clarke WR, et al. Extracranial-intracranial bypass surgery for stroke prevention in hemodynamic cerebral ischemia : the Carotid Occlusion Surgery Study randomized trial. JAMA. 2011 ; 306 : 1983-92.
PubMed
6) Hosoda K, Kawaguchi T, et al : Cerebral vasoreactivity and internal carotid artery flow help to identify patients at risk for hyperperfusion after carotid endarterectomy. Stroke. 2001 ; 32 : 1567-73.
PubMed
7) Kaku Y, Yoshimura S, et al. Factors predictive of cerebral hyperper fusion after carotid angioplasty and stent placement. AJNR Am J Neuroradiol. 2004 ; 25 : 1403-8.
 
8) Tawakol A, Migrino RQ, et al. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol. 2006 ; 48 : 1818-24.
PubMed
P.105 掲載の参考文献
1) Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery disease. JAMA. 1995 ; 273 : 1421-8.
PubMed
2) Halliday A, Mansfield A, Marro J, et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms : randomized controlled trial. Lancet. 2004 ; 363 : 1491-502.
PubMed
3) Nor th American Symotomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Eng J Med. 1991 ; 325 : 445-53.
 
4) Barnet HJ, Taylor DE, Eliasziw M, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Carotid Endarterectomy Trial Collaborators. N Engl J Med. 1998 ; 339 : 1415-25.
 
5) Rondomised trial of endarterectomy for recently symptomatic carotid stenosis : final results of MRC European Carotid Surgery Trial (ECST). Lancet. 1998 ; 351 : 1379-87.
PubMed
6) Fox AJ, Eliasziw M, Rothwell PM, et al. Identification, prognosis, and management of patients with carotid artery near occlusion. AJNR Am J Neuroradiol. 2005 ; 26 : 2086-4.
PubMed
7) Kappelle LJ, Eliasziw M Fox AJ, et al. Importance of intracranial atherosclerotic disease in patients with symptomatic stenosis of the internal carotid artery. The North American Carotid Endarterectomy Trial. Stroke. 1999 ; 30 : 282-6.
PubMed
8) Gasecki AP, Eliasziw M, Ferguson GG, et al. Long-term prognosis and effect of endarterectomy in patients with symptomatic severe carotid stenosis and contralateral carotid stenosis or occlusion : results from NASCET. North American Carotid Endarterectomy Trial (NASCET) Group. J Neurosurg. 1995 ; 83 : 778-82.
PubMed
9) Eliasziw M et al. Significance of plaque ulceration in symptomatic patients with high-grade carotid stenosis. Stroke. 1994 ; 25 : 304-8.
PubMed
10) Benavente O, Eliaziw M, Streifler JY, et al. Prognosis after transient monocular blindness asociated with carotid-artery stenosis. N Engl J Med. 2001 ; 345 : 1084-90.
 
11) Baker WH, Howard VJ, Howard G, et al. Effect of contralateral occlusion on long-term efficacy of endarterectomy in the Asymptomatic Carotid Atherosclerosis Study (ACAS). Stroke. 2000 ; 31 : 2330-4.
PubMed
12) Rothwell PM, Eliasziw M, et al. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet. 2004 ; 363 : 915-24.
PubMed
13) Rothwell PM, Mehta Z, et al. From subgroups to individuals : general principles and the example of carotid endarterectomy. Lancet. 2005 ; 365 : 256-65.
PubMed
14) Abbott AL. Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis. Results of a systematic review and analysis. Stroke. 2009 ; 40 : e573-83.
PubMed
15) Yadav JS, Wholey MH, Kuntz RE, et al. Protected carotidartery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004 ; 351 : 1493-01.
PubMed
16) Mas JL, Chatellier G, Beyssen B, et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med. 2006 ; 355 : 1660-71.
PubMed
17) The SPACE Collaborative Group. 30 day result from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients : randomized noninferiority trial. Lancet. 2006 ; 368 : 1239-47.
 
18) International Carotid Stenting Study investigators. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study) : an interim analysis of a randomised controlled trial. Lancet. 2010 ; 376 : 1062-73.
 
19) Brott TG, Hobson RW 2 nd, Howard G, et al. Stenting and endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010 ; 363 : 11-23.
 
20) Rosenfield K, Matsumura JS, Chatur vedi S, et al. Randomized trial of stent versus surgery for asymptomatic carotid stenosis. N Engl J Med. 2016 ; 374 (11) : 1011-20.
 
21) Gurm HS, Yadav JS, Fayad P, et al. Long-term results of carotid stnting versus endarterectomy in high-risk patients. N Engl J Med. 2008 ; 358 : 1572-9.
PubMed
22) Mas JL, Trinquart L, Leys D, et al. Endarterectomy versus angioplasty in patients with symptomatic severe carotid stenosis (EVA-3 S) trial : results up to 4 years from a randomised, multicentre trial. Lancet Neurol. 2008 ; 7 : 885-92.
 
23) Eckstein HH, Ringleb P, Allenberg JR, et al. Results of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years : a multinational, prospective, randomised trial. Lancet Neurol. 2008 ; 7 : 893-902.
 
24) Bonati LH, Dobson J, Featherstone RL, et al. Long-term outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis : the International Carotid Stenting Study (ICSS) randomised trial. Lancet. 2015 ; 385 : 529-38.
PubMed
25) Silver FL, Mackey A, Clark WM, et al. Safety of stenting and endarterectomy by symptomatic status in the Carotid Revascularization Endarterectomy versus Stenting Trial. Stroke. 2011 ; 42 : 675-80.
PubMed
26) Carotid Stenting Trialists' Collaboration. Short-term outcome af ter stent ing versus endar terectmy for symptomatic carotid stenosis : a preplanned meta-analysis of individual patient data. Lancet. 2010 ; 376 : 1062-73.
 
27) Goldstein LB, Bushnell CD, Adams RJ, et al. Guidelines for the primary prevention of stroke : a guideline for healthcare professionals from the American Heart Association/American Stroke. Association. Stroke. 2011 ; 42 : 517-84.
PubMed
28) Furie KL, Kasner SE, Adams RJ, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack : a guideline for healthcare professionals from the american heart association/american stroke association. Stroke. 2011 ; 42 : 227-76.
PubMed
29) Brott TG, Halperin JL, Abbara S, et al. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease : executive summary : a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery. Stroke. 2011 ; 42 : e420-63.
 
30) Meschia JF, Bushnell C, Boden-Albala B, et al ; on behalf of the American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, Council on Functional Genomics and Translational Biology, and Council on Hypertension. Guidelines for the primary prevention of stroke : a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014 ; 45 : 3754-823.
 
31) Kernan WN, Ovbiagele B, Black HR, et al ; on behalf of the American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Peripheral Vascular Disease. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack : a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014 ; 45 : 2160-236.
 
32) 日本脳卒中学会 脳卒中ガイドライン編集員会編. 脳卒中治療ガイドライン 2015, 協和企画, 東京, 2015.
 
33) Bonati LH, et al. Percutaneous transluminal balloon angioplasty and stenting for carotid artery stenosis. Cochrane Database Syst Rev. 2012 ; 9 : CD000515.
PubMed
34) Chaturvedi S, Sacco RL. How recent data have impacted the treatment of internal carotid artery stenosis. J Am Coll Cardiol. 2015 ; 65 : 1134-43.
PubMed
P.109 掲載の参考文献
1) Yadav JS, Wholey MH, Kuntz RE, et al. Protected carotidartery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004 ; 351 : 1493-501.
PubMed
2) Mas JL, Chatellier G, Beyssen B, et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med. 2006 ; 355 : 1660-71.
PubMed
3) The SPACE Collaborative Group. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients : a randomized non-inferiority trial. Lancet. 2006 ; 368 : 1239-47.
 
4) Brott TG, Hobson RW II, Howard G, et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010 ; 363 : 11-23.
 
5) Rosenfield K, Naksynyra JS, Chaturvedi S, et al. Randomized trial of stent versus surgery for asymptomatic carotid stenosis. N Engl J Med. 2016 ; 374 : 1011-20.
PubMed
6) Lal BK, Meschia JF, Brott TG. CREST-2 : Guiding treatments for asymptomatic carotid disease. Endovas Today. September 2013 : 73-6.
 
7) Chaturvedi S, Sacco RL. Are the current risks of asymptomatic carotid stenosis exaggerated? Further evidence supporting the CREST 2 trial. 72 : 1233-4.
PubMed
8) Reiff T, Stingele R, Eckstein HH, et al. Stent protected angioplasty in asymptomatic carotid artery stenosis vs. endar terectomy : SPACE2? A three-arm randomized controlled clinical trial. Int J Stroke. 2009 ; 4 : 294-9.
 
9) Chimowitz MI, Lynn MJ, Derdeyn CP, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011 ; 365 : 993-1003.
PubMed
10) Zaidat OO, Fitzsimmons BF, KeithWoodward B, at al. Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis. The VISSIT randomized clinical trial. JAMA. 2015 ; 313 : 1240-8.
 

II 内科的治療

P.121 掲載の参考文献
1) den Hartog AG, Achterberg S, et al. Asymptomatic carotid artery stenosis and the risk of ischemic stroke according to subtype in patients with clinical manifest arterial disease. Stroke. 2013 ; 44 : 1002-7.
PubMed
2) Nicolaides AN, Kakkos SK, et al. Severity of asymptomatic carotid stenosis and risk of ipsilateral hemispheric ischaemic events : results from the ACSRS study. Eur J Vasc Endovasc Surg. 2005 ; 30 : 275-84.
PubMed
3) Abbott AL, Chambers BR, et al. Embolic signals and prediction of ipsilateral stroke or transient ischemic attack in asymptomatic carotid stenosis : a multicenter prospective cohort study. Strok. 2005 ; 36 : 1128-33.
 
4) Goessens BM, Visseren FL, Kappelle LJ, et al. Asymptomatic carotid artery stenosis and the risk of new vascular events in patients with manifest arterial disease. the SMART study. Stroke. 2007 ; 38 : 1470-5.
PubMed
5) Marquardt L, Geraghty OC, et al. Low risk of ipsilateral stroke in patients with asymptomatic carotid stenosis on bbest medical treatment : a prospective, population-based study. Stroke. 2010 ; 41 : e11-7.
 
6) Walker MD, Marler JR, et al. Endar terectomy for asymptomatic carotid artery stenosis : Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA. 1995 ; 273 : 1421-8.
 
7) Rothwell PM, Goldstein LB, et al. Carotid endarterectomy for asymptomatic carotid stenosis : Asymptomatic carotid surgery trial. Stroke. 2004 ; 35 : 2425-7.
PubMed
8) Halliday A, Harrison M, et al. 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1) : a multicentre randomised trial. Lancet. 2010 ; 376 : 1074-84.
PubMed
9) Jonas DE, Feltner C, et al. Screening for asymptomatic carotid artery stenosis : a systematic review and metaanalysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2014 ; 161 : 336-46.
 
10) Cunningham EJ, Mayberg MR. Asymptomatic carotid occlusive disease. In ; Mohr JP, et al, eds : Stroke : Pathophysiology, Diagnosis and Management. 4 th ed, Churchill Livingstone, New York, 2004, p1269-78.
 
11) Polak JF, Shemanski L, et al. Hypoechoic plaque at US of the carotid artery : An independent risk factor for incident stroke in adults aged 68 years and older : Cardiovascular health study. Radiology. 1998 ; 208 : 649-54.
 
12) King A, Shipley M, et al. The Effect of medical treatments on stroke risk in asymptomatic carotid stenosis. Stroke. 2013 ; 44 : 542-6.
PubMed
13) Katakami N, Kim YS, et al. The phosphodiesterase inhibitor cilostazol induces regression of carotid atherosclerosis in subjects with type 2 diabetes mellitus : principal results of the Diabetic Atherosclerosis Prevention by Cilostazol (DAPC) study : a randomized trial. Circulation. 2010 ; 121 : 2584-91.
PubMed
14) Shinohara Y, Katayama Y, et al. Cilostazol for prevention of secondary stroke (CSPS 2) : an aspirin-controlled, double-blind, randomised non-inferiority trial. Lancet Neurol. 2010 ; 9 : 959-68.
PubMed
15) Harker LA, Boissel JP, et al. Comparative safety and tolerability of clopidogrel and aspirin : results from CAPRIE. CAPRIE Steering Committee and Investigators. Clopidogrel versus aspirin in patients at risk of ischaemic events. Drug Saf. 1999 ; 21 (4) : 325-35.
 
16) Antithrombotic Trialists' (ATT) Collaboration, Baigent C, Blackwell L, et al. Aspirin in the primary and secondary prevention of vascular disease : collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009 ; 373 : 1849-60.
PubMed
17) He J, Whelton PK, et al. Aspirin and risk of hemorrhagic stroke : a meta-analysis of randomized controlled trials. JAMA. 1998 ; 280 : 1930-5.
PubMed
18) Shinohara Y, Nishimaru K, et al. Sarpogrelate-Aspirin Comparative Clinical Study for Ef ficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS) : A randomized, double-blind, aspirin-controlled trial. Stroke. 2008 ; 39 : 1827-33.
 
19) Uemura N, Sugano K, et al. Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients : the results from the MAGIC study. J Gastroenterol. 2014 ; 49 : 814-24.
 
20) Sudlow CL, Mason G, et al. Thienopyridine derivatives versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients. Cochrane Database Syst Rev. 2009 ; 4 : CD001246.
PubMed
21) Gotoh F, Tohgi H, et al. Cilostazol stroke prevention study : A placebo-controlled double-blind trial for secondary prevention of cerebral infarction. J Stroke Cerebrovasc Dis. 2000 ; 9 : 147-57.
PubMed
22) Wang JG, Staessen JA, et al. Carotid intima-media thickness and antihyper tensive treatment : a meta-analysis of randomized controlled trials. Stroke. 2006 ; 37 : 1933-40.
 
23) Rothwell PM, Howard SC, et al. Relationship between blood pressure and stroke risk in patients with symptomatic carotid occlusive disease. Stroke. 2003 ; 34 : 2583-90.
PubMed
24) Sillesen H, Amarenco P, et al. Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis : a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2008 ; 39 : 3297-302.
PubMed
25) Sever PS, Dahlof B, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA) : a multicentre randomised controlled trial. Lancet. 2003 ; 361 : 1149-58.
 
26) Colhoun HM, Betteridge DJ, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS) : multicentre randomized placebo-controlled trial. Lancet. 2004 ; 364 : 685-96.
PubMed
27) Kearney PM, Blackwell L, et al. Efficacy of cholesterollowering therapy in 18,686 people with diabetes in 14 randomized trials of statins : a meta-analysis. Lancet. 2008 ; 371 : 117-25.
PubMed
28) Nakamura H, Arakawa K, et al. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study) : a prospective randomized controlled trial. Lancet. 2006 ; 368 : 1155-63.
PubMed
29) Amarenco P, Labreuche J, et al. Statins in stroke prevention and carotid atherosclerosis : systematic review and up-todate meta-analysis. Stroke. 2004 ; 35 : 2902-9.
 
30) Mita T, Watada H, et al. Eicosapentaenoic acid reduces the progression of carotid intima-media thickness in patients with type 2 diabetes. Atherosclerosis. 2007 ; 191 : 162-7.
PubMed
31) Tanaka K, Ishikawa Y, et al. Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients : subanalysis of the JELIS trial. Stroke. 2008 ; 39 : 2052-8.
PubMed
32) Ray KK, Seshasai SR, et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus : a meta-analysis of randomised controlled trials. Lancet. 2009 ; 373 : 1765-72.
PubMed
33) Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008 ; 358 : 2545-59.
 
34) Lincof f AM, Wolski K, et al. Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus : a meta-analysis of randomized trials. JAMA. 2007 ; 298 : 1180-8.
 
35) Mazzone T, Meyer PM, et al. Ef fect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes : a randomized trial. JAMA. 2006 ; 296 : 2572-81.
 
36) UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998 ; 352 : 854-65.
PubMed
37) Johansen OE, Neubacher D, et al. Cardiovascular safety with linagliptin in patients with type 2 diabetes mellitus : a pre-specified, prospective, and adjudicated meta-analysis of a phase 3 programme. Cardiovasc Diabetol. 2012 ; 11 : 3.
PubMed
38) Gaede P, Lund-Andersen H, et al. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Eng J Med. 2008 ; 358 : 580-91.
 
P.132 掲載の参考文献
1) Rothwell PM, Eliasziw M, Gutnikov SA, et al. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet. 2003 ; 361 (9352) : 107-16.
PubMed
2) Chen ZM, Sandercock P, Pan HC, et al. Indications for early aspirin use in acute ischemic stroke : A combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups. Stroke. 2000 ; 31 (6) : 1240-9.
 
3) Lee YS, Bae HJ, Kang DW, et al. Cilostazol in Acute Ischemic Stroke Treatment (CAIST Trial) : a randomized double-blind non-inferiority trial. Cerebrovasc Dis. 2011 ; 32 (1) : 65-71.
 
4) 日本脳卒中学会 脳卒中ガイドライン委員会編. 脳卒中治療ガイドライン 2015, 協和企画, 東京, 2015.
 
5) Zhang J, Yang J, Chang X, et al. Ozagrel for acute ischemic stroke : a meta-analysis of data from randomized controlled trials. Neurol Res. 2012 ; 34 (4) : 346-53.
 
6) Johnston SC, Amarenco P, Albers GW, et al. Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack. N Engl J Med. 2016 May 10. [Epub ahead of print]
 
7) Markus HS, Droste DW, Kaps M, et al. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection : the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation. 2005 ; 111 (17) : 2233-40.
PubMed
8) Wong KS, Chen C, Fu J, et al. Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study) : a randomised, open-label, blinded-endpoint trial. Lancet Neurol. 2010 ; 9 (5) : 489-97.
PubMed
9) Wang Y, Zhao X, Liu L, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 2013 ; 369 (1) : 11-9.
PubMed
10) Yi X, Lin J, Wang C, et al. A comparative study of dual versus monoantiplatelet therapy in patients with acute largeartery atherosclerosis stroke. J Stroke Cerebrovasc Dis. 2014 ; 23 (7) : 1975-81.
 
11) Sandercock PA, Counsell C, Kamal AK. Anticoagulants for acute ischaemic stroke. Cochrane Database Syst Rev. 2008 ; (4) : CD000024.
PubMed
12) Wong KS, Chen C, Ng PW, et al. Low-molecular-weight heparin compared with aspirin for the treatment of acute ischaemic stroke in Asian patients with large artery occlusive disease : a randomised study. Lancet Neurol. 2007 ; 6 (5) : 407-13.
PubMed
13) Paciaroni M, Agnelli G, Micheli S, et al. Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke : a meta-analysis of randomized controlled trials. Stroke. 2007 ; 38 (2) : 423-30.
PubMed
14) Kennedy J, Hill MD, Ryckborst KJ, et al. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER) : a randomised controlled pilot trial. Lancet Neurol. 2007 ; 6 (11) : 961-9.
PubMed
15) Ni Chroinin D, Asplund K, Asberg S, et al. Statin therapy and outcome after ischemic stroke : systematic review and meta-analysis of obser vational studies and randomized trials. Stroke. 2013 ; 44 (2) : 448-56.
 
16) Merwick A, Albers GW, Arsava EM, et al. Reduction in early stroke risk in carotid stenosis with transient ischemic attack associated with statin treatment. Stroke. 2013 ; 44 (10) : 2814-20.
PubMed
17) Schrader J, Luders S, Kulschewski A, et al. The ACCESS Study : evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors. Stroke. 2003 ; 34 (7) : 1699-703. Epub 2003 Jun 19.
 
18) Sandset EC, Bath PM, Boysen G, et al. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST) : a randomised, placebo-controlled, double-blind trial. Lancet. 2011 ; 377 (9767) : 741-50.
PubMed
19) He J, Zhang Y, Xu T, et al. Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke : the CATIS randomized clinical trial. JAMA. 2014 ; 311 (5) : 479-89.
 
20) Rothwell PM, Eliasziw M, Gutnikov SA, et al. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet. 2004 ; 363 (9413) : 915-24.
PubMed
21) Johansson E, Cuadrado-Godia E, Hayden D, et al. Recurrent stroke in symptomatic carotid stenosis awaiting revascularization : A pooled analysis. Neurology. 2016 ; 86 (6) : 498-504.
PubMed
22) Shahidi S, Owen-Falkenberg A, Hjerpsted U, et al. Urgent best medical therapy may obviate the need for urgent surgery in patients with symptomatic carotid stenosis. Stroke. 2013 ; 44 (8) : 2220-5.
PubMed
23) Payne DA, Jones CI, Hayes PD, et al. Beneficial effects of clopidogrel combined with aspirin in reducing cerebral emboli in patients undergoing carotid endarterectomy. Circulation. 2004 ; 109 (12) : 1476-81.
PubMed
24) Sharpe RY, Dennis MJ, Nasim A, et al. Dual antiplatelet therapy prior to carotid endarterectomy reduces post-operative embolisation and thromboembolic events : post-operative transcranial Doppler monitoring is now unnecessary. Eur J Vasc Endovasc Surg. 2010 ; 40 (2) : 162-7.
PubMed
25) Yoshimoto T, Fujimoto S, Muraki M, et al. Cilostazol may suppress restenosis and new contralateral carotid artery stenosis after carotid endarterectomy. Neurol Med Chir (Tokyo). 2010 ; 50 (7) : 525-9.
PubMed
26) Yamagami H, Sakai N, Matsumaru Y, et al. Periprocedural cilostazol treatment and restenosis after carotid artery stenting : the Retrospective Study of In-Stent Restenosis after Carotid Artery Stenting (ReSISteR-CAS). J Stroke Cerebrovasc Dis. 2012 ; 21 (3) : 193-9.
PubMed
27) McGirt MJ, Perler BA, Brooke BS, et al. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors reduce the risk of perioperative stroke and mortality after carotid endarterectomy. J Vasc Surg. 2005 ; 42 (5) : 829-36 ; discussion 36-7.
PubMed
28) Verzini F, De Rango P, Parlani G, et al. Effects of statins on early and late results of carotid stenting. J Vasc Surg. 2011 ; 53 (1) : 71-9 ; discussion 9.
PubMed
29) Lal BK, Beach KW, Roubin GS, et al. Restenosis after carotid artery stenting and endarterectomy : a secondary analysis of CREST, a randomised controlled trial. Lancet Neurol. 2012 ; 11 (9) : 755-63.
 
30) Toyoda K, Yasaka M, Uchiyama S, et al. Blood pressure levels and bleeding events during antithrombotic therapy : the Bleeding with Antithrombotic Therapy (BAT) Study. Stroke. 2010 ; 41 (7) : 1440-4.
PubMed
31) Sillesen H, Amarenco P, Hennerici MG, et al. Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis : a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2008 ; 39 (12) : 3297-302.
PubMed
32) Brott TG, Halperin JL, Abbara S, et al. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease : a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInter ventional Surger y, Society for Vascular Medicine, and Society for Vascular Surgery. Stroke. 2011 ; 42 (8) : e464-540.
 
P.141 掲載の参考文献
1) Takemoto M, Liao JK. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler Thromb Vasc Biol. 2001 ; 21 : 1712-9.
PubMed
2) Ray KK, Cannon CP. The potential relevance of the multiple lipid-independent (pleiotropic) effects of statins in the management of acute coronary syndromes. J Am Coll Cardiol. 2005 ; 46 : 1425-33.
PubMed
3) Davignon J. Pleiotropic effects of pitavastatin. Br J Clin Pharmacol. 2012 ; 73 : 518-35.
PubMed
4) Pasceri V, Patti G, Nusca A, et al. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention : results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study. Circulation. 2004 ; 110 : 674-8.
PubMed
5) Yoshimura S, Yamada K, Kawasaki M, et al. High-intensity signal on time-of-flight magnetic resonance angiography indicates carotid plaques at high risk for cerebral embolism during stenting. Stroke. 2011 ; 42 : 3132-7.
PubMed
6) Crisby M, Nordin-Fredriksson G, Shah PK, et al. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques : implications for plaque stabilization. Circulation. 2001 ; 103 : 926-33.
PubMed
7) Martin-Ventura JL, Blanco-Colio LM, Gomez-Hernandez A, et al. Intensive treatment with atorvastatin reduces inflammation in mononuclear cells and human atherosclerotic lesions in one month. Stroke. 2005 ; 36 : 1796-800.
PubMed
8) Nakamura T, Obata JE, Kitta Y, et al. Rapid stabilization of vulnerable carotid plaque within 1 month of pitavastatin treatment in patients with acute coronary syndrome. J Cardiovasc Pharmacol. 2008 ; 51 : 365-71.
PubMed
9) Koutouzis M, Paraskevas KI, Rallidis LS, et al. Statin treatment, carotid atherosclerotic plaque macrophage infiltration and circulating inflammatory markers. Open Cardiovasc Med J. 2008 ; 2 : 110-4.
PubMed
10) Yamada K, Yoshimura S, Kawasaki M, et al. Effects of atorvastatin on carotid atherosclerotic plaques : a randomized trial for quantitative tissue characterization of carotid atherosclerotic ultrasound. Cerebrovasc Dis. 2009 ; 28 : 417-24.
PubMed
11) Takayama K, Taki W, Toma N, et al. Effect of Pitavastatin on Preventing Ischemic Complications with Carotid Artery Stenting : Study. Cardiovasc Intervent Radiol. 2014 ; 37 : 1436-43.
PubMed
12) Groschel K, Ernemann U, Schulz JB, et al. Statin therapy at carotid angioplasty and stent placement : effect on procedure-related stroke, myocardial infarction, and death. Radiology. 2006 ; 240 : 145-51.
PubMed
13) Verzini F, De Rango P, Parlani G, et al. Effects of statins on early and late results of carotid stenting. J Vasc Surg. 2011 ; 53 : 71-9 ; discussion 79.
PubMed
14) Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia : a systematic review and meta-analysis. Lancet Neurol. 2009 ; 8 : 1006-18.
PubMed
15) McGirt MJ, Perler BA, Brooke BS, et al. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors reduce the risk of perioperative stroke and mortality after carotid endarterectomy. J Vasc Surg. 2005 ; 42 : 829-36 ; discussion 836-7.
 
16) Heyer EJ, Mergeche JL, Wang S, et al. Impact of Cognitive Dysfunction on Survival in Patients With and Without Statin Use Following Carotid Endarterectomy. Neurosurgery. 2015 ; 77 : 880-7.
PubMed

III 外科的治療 (1) : 頚動脈内膜剥離術 ( CEA )

P.153 掲載の参考文献
1) 日本脳卒中学会 脳卒中ガイドライン委員会編. 脳卒中治療ガイドライン 2015, 協和企画, 東京, 2015.
 
2) Sundt TM, Sandok BA, Whisnant JP. Carotid endarterectomy. Complications and preoperative assessment of risk. Mayo Clin Proc. 1975 ; 50 : 301-6.
PubMed
3) Sundt TM Jr, Sharbrough FW, Piepgras DG, et al. Correlation of cerebral blood flow and electroencephalographic changes during carotid endarterectomy : with results of surgery and hemodynamics of cerebral ischemia. Mayo Clin Proc. 1981 ; 56 : 533-43.
PubMed
4) Zeiger HE Jr, Zampella EJ, Naftel DC, et al. A prospective analysis of 142 carotid endarterectomies for occlusive vascular disease, 1979-1985. J Neurosurg. 1987 ; 67 : 540-4.
PubMed
5) Sieber FE, Toung TJ, Diringer MN, et al. Preoperative risks predict neurological outcome of carotid endarterectomy related stroke. Neurosurgery. 1992 ; 30 : 847-54.
PubMed
6) McCrory DC, Goldstein LB, Samsa GP, et al. Predicting complications of carotid endarterectomy. Stroke. 1993 ; 24 : 1285-91.
PubMed
7) Nor th American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991 ; 325 : 445-53.
PubMed
8) ECST Collaborative Group. Randomised trial of endarterectomy for recently symptomatic carotid stenosis : final results of the MRC European Carotid Surgery Trial (ECST). Lancet. 1998 ; 351 : 1379-87.
 
9) Calvillo-King L, Xuan L, Zhang S, et al. Predicting risk of perioperative death and stroke after carotid endarterectomy in asymptomatic patients : derivation and validation of a clinical risk score. Stroke. 2010 ; 41 : 2786-94.
PubMed
10) Brott TG, Halperin JL, Abbara S, et al ; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines ; American Stroke Assocation ; American Association of Neuroscience Nurses ; American Association of Neurological Surgeons ; American College of Radiology ; American Society of Neuroradiology ; Congress of Neurolgocial Surgeons ; Society of Atherosclerosis Imaging and Prevention ; Society for Cardiovascular Angiography and Interventions ; Society of Interventional Radiology ; Society of NeuroInterventional Surgery ; Society for Vascular Medicine ; Society for Vascular Surgery ; American Academy of Neurology and Society of Cardiovascular Computed Tomography. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease. Stroke. 2011 ; 42 : e464-540.
 
11) Fokkema M, den Har tog AG, Bots ML, et al. Stenting versus surgery in patients with carotid stenosis after previous cervical radiation therapy : systematic review and meta-analysis. Stroke. 2012 ; 43 : 793-801.
 
12) Yadav JS, Wholey MH, Kuntz RE, et al ; Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy Investigators. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004 ; 351 : 1493-501.
PubMed
13) Gates L, Botta R, Schlosser F, et al. Characteristics that define high risk in carotid endarterectomy from the Vascular Study Group of New England. J Vasc Surg. 2015 ; 62 : 929-36.
 
14) Gates PC, Eliasziw M, Algra A, et al ; North American Symptomatic Carotid Endar terectomy Trial Group. Identifying patients with symptomatic carotid artery disease at high and low risk of severe myocardial infarction and cardiac death. Stroke. 2002 ; 33 : 2413-6.
 
15) Kawarada O, Yokoi Y, Morioka N, et al. Carotid stenosis and peripheral artery disease in Japanese patients with coronary artery disease undergoing coronary artery bypass grafting. Circ J. 2003 ; 67 : 1003-6.
PubMed
16) 日本循環器学会, 日本冠疾患学会, 日本胸部外科学会, 日本外科学会, 日本小児循環器学会, 日本心臓血管外科学会, 日本心臓病学会, 日本心不全学会, 日本麻酔科学会合同研究班. 非心臓手術における合併心疾患の評価と管理に関するガイドライン (2014年改訂版).
 
17) Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation. 1995 ; 92 : 657-71.
PubMed
18) Eagle KA, Rihal CS, Mickel MC, et al. Cardiac risk of noncardiac surgery : influence of coronary disease and type of surgery in 3368 operations. CASS Investigators and University of Michigan Heart Care Program. Coronary Artery Surgery Study. Circulation. 1997 ; 96 : 1882-7.
PubMed
19) Hassan SA, Hlatky MA, Boothroyd DB, et al. Outcomes of noncardiac surgery after coronary bypass surgery or coronary angioplasty in the Bypass Angioplasty Revascularization Investigation (BARI). Am J Med. 2001 ; 110 : 260-6.
PubMed
20) Katritsis DG, Ioannidis JP. Percutaneous coronary inter vention versus conser vative therapy in nonacute coronary artery disease : a meta-analysis. Circulation. 2005 ; 111 : 2906-12.
 
21) Stergiopoulos K, Brown DL. Initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease : meta-analysis of randomized controlled trials. Arch Intern Med. 2012 ; 172 : 312-9.
PubMed
22) Poldermans D, Schouten O, Vidakovic R, et al ; DECREASE Study Group. A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery : the DECREASE-V Pilot Study. J Am Coll Cardiol. 2007 ; 49 : 1763-9. Epub 2007 Apr 16.
 
23) McFalls EO, Ward HB, Moritz TE, et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med. 2004 ; 351 : 2795-804.
PubMed
24) POISE Study Group, Devereaux PJ, Yang H, Yusuf S, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial) : a randomised controlled trial. Lancet. 2008 ; 371 : 1839-47.
 
25) Grines CL, Bonow RO, Casey DE Jr, et al ; American Heart Association ; American College of Cardiology ; Society for Cardiovascular Angiography and Interventions ; American College of Surgeons ; American Dental Association ; American College of Physicians. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents : a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation. 2007 ; 115 : 813-8.
 
26) Kirwin JD, Ascer E, Gennaro M, et al. Silent myocardial ischemia is not predictive of myocardial infarction in peripheral vascular surgery patients. Ann Vasc Surg. 1993 ; 7 : 27-32.
 
27) McPhail NV1, Ruddy TD, Barber GG, et al. Cardiac risk stratification using dipyridamole myocardial per fusion imaging and ambulatory ECG monitoring prior to vascular surgery. Eur J Vasc Surg. 1993 ; 7 : 151-5.
 
28) Gianrossi R, Detrano R, Mulvihill D, et al. Exercise-induced ST depression in the diagnosis of coronary artery disease. A meta-analysis. Circulation. 198 ; 80 : 87-98.
 
29) Detrano R, Gianrossi R, Mulvihill D, et al. Exercise-induced ST segment depression in the diagnosis of multivessel coronary disease : a meta analysis. J Am Coll Cardiol. 1989 ; 14 : 1501-8.
PubMed
30) von Knorring J, Lepantalo M. Prediction of perioperative cardiac complications by electrocardiographic monitoring during treadmill exercise testing before peripheral vascular surgery. Surgery. 1986 ; 99 : 610-3.
PubMed
31) Carliner NH, Fisher ML, Plotnick GD, et al. Routine preoperative exercise testing in patients undergoing major noncardiac surgery. Am J Cardiol. 1985 ; 56 : 51-8.
PubMed
32) Rochmis P, Blackburn H. Exercise tests. A survey of procedures, safety, and litigation experience in approximately 170,000 tests. JAMA. 1971 ; 217 : 1061-6.
PubMed
33) Hornsten TR, Bruce RA. Stress testing, safety precautions, and cardiovascular health. J Occup Med. 1968 ; 10 : 640-8.
 
34) 秋岡要. 心筋シンチグラム. 吉川純一編. 冠動脈疾患診断学. 中外医学社, 東京, 2000, p83-8.
 
35) Eagle KA, Coley CM, Newell JB, et al. Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Intern Med. 1989 ; 110 : 859-66.
PubMed
36) Bry JD, Belkin M, O'Donnell TF Jr, et al. An assessment of the positive predictive value and cost-effectiveness of dipyridamole myocardial scintigraphy in patients undergoing vascular surgery. J Vasc Surg. 1994 ; 19 : 112-21 ; discussion 121-4.
 
37) 竹内正明. 心筋虚血の評価における負荷心エコー法 : 3. ドブタミン負荷. 小柳左門, 本間博編. 負荷心エコー法, 中山書店, 東京, 1997, p89-109.
 
38) Eichelberger JP, Schwarz KQ, Black ER, et al. Predictive value of dobutamine echocardiography just before noncardiac vascular surgery. Am J Cardiol. 1993 ; 72 : 602-7.
PubMed
39) Poldermans D, Fioretti PM, Forster T, et al. Dobutamine stress echocardiography for assessment of perioperative cardiac risk in patients undergoing major vascular surgery. Circulation. 1993 ; 87 : 1506-12.
PubMed
40) Hoffmann R, Lethen H, Marwick T, et al. Analysis of interinstitutional observer agreement in interpretation of dobutamine stress echocardiograms. J Am Coll Cardiol. 1996 ; 27 : 330-6.
PubMed
41) Hirsch AT, Haskal ZJ, Her tzer NR, et al ; American Association for Vascular Surgery ; Society for Vascular Surgery ; Society for Cardiovascular Angiography and Interventions ; Society for Vascular Medicine and Biology ; Society of Interventional Radiology ; ACC/AHA Task Force on Practice Guidelines Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease ; American Association of Cardiovascular and Pulmonary Rehabilitation ; National Heart, Lung, and Blood Institute ; Society for Vascular Nursing ; TransAtlantic Inter-Society Consensus ; Vascular Disease Foundation. : ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic) : a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Inter ventions, Society for Vascular Medicine and Biology, Society of Interventional Ra
 
42) Mas JL, Chatellier G, Beyssen B, et al. EVA-3S Investigators. Endar terectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med. 2006 ; 355 : 1660-71.
 
43) International Carotid Stenting Study investigators, Ederle J, Dobson J, Featherstone RL, et al. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study) : an interim analysis of a randomised controlled trial. Lancet. 201 ; 375 : 985-97.
 
44) Ahmed B, Al-Khaf faf H. Prevalence of significant asymptomatic carotid artery disease in patients with peripheral vascular disease : a meta-analysis. Eur J Vasc Endovasc Surg. 2009 ; 37 : 262-71.
 
45) Araki Y, Kumakura H, Kanai H, et al. Prevalence and risk factors for cerebral infarction and carotid artery stenosis in peripheral arterial disease. Atherosclerosis. 2012 ; 223 : 473-7.
PubMed
46) Fontaine R, Kim M, Kieny R. Surgical treatment of peripheral circulation disorders [in German] Helv Chir Acta. 1954 ; 21 : 499-533.
PubMed
47) Norgren L, Hiatt WR, Dormandy JA, et al. TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007 ; 45S : S5-67.
 
48) TASC II WorkingGroup. 下肢閉塞性動脈硬化症の診断・治療指針 II, 第1版 ed. メディカルトリビューン, 東京, 2007.
 
49) American College of Cardiology Foundation ; American Heart Association Task Force ; Society for Cardiovascular Angiography and Interventions ; Society of Interventional Radiology ; Society for Vascular Medicine ; Society for Vascular Surgery, Rooke TW, Hirsch AT, Misra S, et al. 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline). Vasc Med. 2011 ; 16 : 452-76.
 
50) Ayerdi J, Sampson LN, Deshmukh N, et al. Carotid endarterectomy in patients with renal insufficiency : Should selection criteria be dif ferent in patients with renal insufficiency? Vasc Surg. 2001 ; 35 : 429-35.
 
51) Debing E, Van den Brande P. Chronic renal insufficiency and risk of early mortality in patients undergoing carotid endarterectomy. Ann Vasc Surg. 2006 ; 20 : 609-13.
PubMed
52) Sidawy AN, Aidinian G, Johnson ON 3 rd, et al. Effect of chronic renal insuf ficiency on outcomes of carotid endarterectomy. J Vasc Surg. 2008 ; 48 : 1423-30.
 
53) Mathew A, Eliasziw M, Devereaux PJ, et al ; North American Symptomatic Carotid Endarterectomy Trial (NASCET) Collaborators. Carotid endarterectomy benefits patients with CKD and symptomatic high-grade stenosis. J Am Soc Nephrol. 2010 ; 21 : 145-52.
PubMed
54) Axelrod DA, Upchurch GR Jr, DeMonner S, et al. Perioperative cardiovascular risk stratification of patients with diabetes who undergo elective major vascular surgery. J Vasc Surg. 2002 ; 35 : 894-901.
PubMed
55) Ballotta E, Da Giau G, Renon L. Is diabetes mellitus a risk factor for carotid endarterectomy? A prospective study. Surgery. 2001 ; 129 : 146-52.
PubMed
56) Ahari A, Bergqvist D, Troeng T, et al. Diabetes mellitus as a risk factor for early outcome after carotid endarterectomy-a population-based study. Eur J Vasc Endovasc Surg. 1999 ; 18 : 122-6.
PubMed
57) Tu JV, Wang H, Bowyer B, et al ; Participants in the Ontario Carotid Endarterectomy Registry. Risk factors for death or stroke after carotid endarterectomy : observations from the Ontario Carotid Endarterectomy Registry. Stroke. 2003 ; 34 : 2568-73.
PubMed
58) Akbari CM, Pomposelli FB Jr, Gibbons GW, et al. Diabetes mellitus : a risk factor for carotid endarterectomy? J Vasc Surg. 1997 ; 25 : 1070-5 ; discussion 1075-6.
 
59) Pistolese GR, Appolloni A, Ronchey S, et al. Carotid endarterectomy in diabetic patients. J Vasc Surg. 2001 ; 33 : 148-54.
PubMed
60) Hamdan AD, Saltzberg SS, Sheahan M, et al. Lack of association of diabetes with increased postoperative mortality and cardiac morbidity : results of 6565 major vascular operations. Arch Surg. 2002 ; 137 : 417-21.
PubMed
61) Mizuhashi S, Kataoka H, Sano N, et al. Impact of diabetes mellitus on characteristics of carotid plaques and outcomes after carotid endarterectomy. Acta Neurochir (Wien). 2014 ; 156 : 927-33.
PubMed
62) Borhani Haghighi A, Yousefi S, Bahramali E, et al. Demographic and Technical Risk Factors of 30-Day Stroke, Myocardial Infarction, and/or Death in Standard- and High-Risk Patients Who Underwent Carotid Angioplasty and Stenting. Interv Neurol. 2015 ; 3 : 165-73.
PubMed
63) Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus : a randomized prospective 6-year study. Diabetes Res Clin Pract. 1995 ; 28 : 103-17.
PubMed
64) Tominaga M, Eguchi H, Manaka H, et al. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care. 1999 ; 22 : 920-4.
 
65) Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008 ; 358 : 2545-59.
 
67) 日本糖尿病学会編. 科学的根拠に基づく糖尿病診療ガイドライン 2013, 南江堂, 東京, 2013.
 
68) Balkau B, Hu G, Qiao Q, et al. DECODE Study Group ; European Diabetes Epidemiology Group. Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study. Diabetologia. 2004 ; 47 : 2118-28.
 
69) Nakagami T ; DECODA Study Group. Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin. Diabetologia. 2004 ; 47 : 385-94.
 
70) Chaturvedi S, Bruno A, Feasby T, et al ; Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Carotid endarterectomy--an evidence-based review : report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2005 ; 65 : 794-801.
 
71) Alonso-Coello P, Bellmunt S, McGorrian C,et al ; American College of Chest Physicians. Antithrombotic therapy in peripheral artery disease : Antithrombotic Therapy and Prevention of Thrombosis, 9 th ed : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 ; 141 (2 Suppl) : e669S-90S.
 
72) Lindblad B, Persson NH, Takolander R, et al. Does low-dose acetylsalicylic acid prevent stroke after carotid surgery? A double-blind, placebo-controlled randomized trial. Stroke. 1993 ; 24 : 1125-8.
PubMed
73) Taylor DW, Barnett HJ, Haynes RB, et al. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy : a randomised controlled trial. ASA and Carotid Endarterectomy (ACE) Trial Collaborators. Lancet. 1999 ; 353 : 2179-84.
PubMed
74) Payne DA, Jones CI, Hayes PD, et al. Beneficial effects of clopidogrel combined with aspirin in reducing cerebral emboli in patients undergoing carotid endarterectomy. Circulation. 2004 ; 109 : 1476-81.
PubMed
75) Sharpe RY, Dennis MJ, Nasim A, et al. Dual antiplatelet therapy prior to carotid endarterectomy reduces post-operative embolisation and thromboembolic events : post-operative transcranial Doppler monitoring is now unnecessary. Eur J Vasc Endovasc Surg. 2010 ; 40 : 162-7.
PubMed
76) de Borst GJ, Hilgevoord AA, de Vries JP, et al. Influence of antiplatelet therapy on cerebral micro-emboli after carotid endarterectomy using postoperative transcranial Doppler monitoring. Eur J Vasc Endovasc Surg. 2007 ; 34 : 135-42.
 
77) Yoshimoto T, Fujimoto S, Muraki M, et al. Cilostazol may suppress restenosis and new contralateral carotid artery stenosis after carotid endarterectomy. Neurol Med Chir (Tokyo). 2010 ; 50 : 525-9.
PubMed
78) Kennedy J, Quan H, Buchan AM, et al. Statins are associated with better outcomes after carotid endarterectomy in symptomatic patients. Stroke. 2005 ; 36 : 2072-6.
PubMed
79) McGirt MJ, Perler BA, Brooke BS, et al. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors reduce the risk of perioperative stroke and mortality after carotid endarterectomy. J Vasc Surg. 2005 ; 42 : 829-36 ; discussion 836-7.
 
80) Kapoor AS, Kanji H, Buckingham J, et al. Strength of evidence for perioperative use of statins to reduce cardiovascular risk : systematic review of controlled studies. BMJ. 2006 ; 333 : 1149.
PubMed
81) Schouten O, Boersma E, Hoeks SE, et al. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. Fluvastatin and perioperative events in patients undergoing vascular surgery. N Engl J Med. 2009 ; 361 : 980-9.
 
82) Dunkelgrun M, Boersma E, Schouten O, et al ; Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mor tality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery : a randomized controlled trial (DECREASE-IV). Ann Surg. 2009 ; 249 : 921-6.
 
83) Durazzo AE, Machado FS, Ikeoka DT, et al. Reduction in cardiovascular events after vascular surgery with atorvastatin : a randomized trial. J Vasc Surg. 2004 ; 39 : 967-75 ; discussion 975-6.
 
84) Schouten O, Boersma E, Hoeks SE, et al ; Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. Fluvastatin and perioperative events in patients undergoing vascular surgery. N Engl J Med. 2009 ; 361 : 980-9.
 
P.163 掲載の参考文献
1) Tanimoto S, Ikari Y, Tanabe K, et al. Prevalence of carotid artery stenosis in patients with coronary artery disease in Japanese population. Stroke. 2005 ; 36 : 2094-8.
PubMed
2) Kawaguchi T, Shibata Y, Kimura H, et al. Surgical Results of Carotid Endarterectomy for Asymptomatic Carotid Stenosis : 100 Consecutive Cases. Surg Cereb Stroke (Jpn). 2006 ; 34 : 360-5.
 
3) Kashimoto S, Seki M, Ishiguro T, et al. Nicorandil decreases cardiac events during and after noncardiac surgery. J Clin Anesth. 2007 ; 19 : 44-8.
 
4) Ogasawara K, Inoue T, Kobayashi M, et al. Pretreatment with the free radical scavenger edaravone prevents cerebral hyperperfusion after carotid endarterectomy. Neurosurgery. 2004 ; 55 : 10607.
 
5) Moritz S, Kasprzak P, et al. Accuracy of cerebral monitoring in detecting cerebral ischemia during carotid endarterectomy : a comparison of transcranial Doppler sonography, near-infrared spectroscopy, stump pressure, and somatosensory evoked potentials. Anesthesiology. 2007 ; 107 : 563-9.
PubMed
6) Ogasawara K, Konno H, et al. Transcranial regional cerebral oxygen saturation monitoring during carotid endarterectomy as a predictor of postoperative hyperperfusion. Neurosurgery. 2003 ; 53 : 309-15.
PubMed
7) Dalman JK, Beenakkers IC, Moll FL, et al. Transcranial Doppler monitoring during carotid endarterectomy helps to identify patients at risk of postoperative hyperperfusion. Eur J Vasc Endvasc Surg. 1999 ; 18 : 222-7.
 
8) Fujimoto S, Inoue T, Toyoda K, et al. Early Diagnosis of Hyperperfusion Syndrome Using Transcranial Color-coded Sonography. Neurosonology. 2004 ; 17 (2) : 72-5.
 
9) Awad N, Choudry R, Durinka J, et al. Importance of technical preparation of intraarterial shunts to prevent iatrogenic arterial injury during urgent procedures. Vasc Endovascular Surg. 2013 ; 47 (2) : 106-8.
PubMed
P.174 掲載の参考文献
1) 飯原弘二. 不安定プラークを有する頸動脈狭窄症に対する内膜剥離術 (CEA). 脳外速報. 2006 ; 16 : 313-20.
Medical*Online
2) Iihara K, Murao K, Sakai N, et al. Outcome of carotid endarterectomy and stent insertion based on grading of carotid endarterectomy risk : a 7-year prospective study. J Neurosurg. 2006 ; 105 : 546-54.
 
3) 飯原弘二. 頚動脈内膜剥離術 (CEA). 脳外速報. 2010 ; 20 : 16-22.
Medical*Online
P.181 掲載の参考文献
1) Inoue T, Tsutsumi K, Ohwaki K, et al. Stratification of intraoperative ischemic impact by somatosensory evoked potential monitoring, diffusion-weighted imaging and magnetic resonance angiography in carotid endarterectomy with routine shunt use. Acta Neurochir (Wien). 2013 ; 155 : 2085-96.
PubMed
2) Aburahma AF, Mousa AY, Stone PA. Shunting during carotid endarterectomy. J Vasc Surg. 2011 ; 54 : 1502-10
 
3) Chongruksut W, Vaniyapong T, Rerkasem K. Routine or selective carotid artery shunting for carotid endarterectomy (and different methods of monitoring in selective shunting). Cochrane Database Syst Rev. 2014 ; 6 : CD000190.
 
4) 遠藤俊郎, 永田泉. 頸動脈高度狭窄病変の本邦治療の現状 : Jcasから. 脳卒中. 2005 ; 27 : 492-7.
Medical*Online
5) 岡田芳和. 頚動脈血栓内膜剥離術-シャントシステムを用いて-. No Shinkei Geka. 2001 ; 29 : 497-508.
 
6) Katano H, Yamada K. Comparison of internal shunts during carotid endarterectomy under routine shunting policy. Neurol Med Chir (Tokyo). 2014 ; 54 : 806-11.
PubMed
P.188 掲載の参考文献
1) 上山憲司. 頚動脈狭窄症に対する頚動脈内膜剥離術の質の向上を目指して. 前編 : 体位決定から内頚動脈確保まで. 脳外速報. 2011 ; 21 : 375-81.
Medical*Online
2) 上山憲司. 頚動脈狭窄症に対する頚動脈内膜剥離術の質の向上を目指して. 後編 : ICG蛍光血管造影から閉創まで. 脳外速報. 2011 ; 21 : 492-502.
Medical*Online
3) 上山憲司, 村橋威夫, 他. 高度石灰化を伴う頚部頚動脈狭窄症における頚動脈内膜剥離術. 脳外速報. 2012 ; 22 : 992-1002.
Medical*Online
4) 宇野昌明, 他. Patch angioplastyを施行した頚動脈内膜剥離術-Hemashild, PTEF, 伏在静脈の比較検討-. 脳卒中の外科. 1999 ; 27 : 203-9.
 
5) 宇野昌明. 頚動脈内膜剥離術. Carotid endarterectomy (CEA). 脳外速報. 2007 ; 17 : 410-7.
 
5) 宇野昌明. 頚動脈内膜剥離術 : 上級編-Patch angioplastyを用いたCEA. 脳外速報. 2012 ; 22 : 394-403.
Medical*Online
6) 宇野昌明. 頚動脈内膜剥離術. 脳外誌. 2012 ; 21 : 943-8.
 
7) 宇野昌明. 手術の実際と工夫 : パッチの使用 : 使用素材と手技. 遠藤俊郎, 永田泉編. 頚動脈内膜剥離術プラクティス : CEAの根拠とスキルがわかる決定版, メディカ出版, 大阪, 2013, p184-90.
 
8) 山田和雄, 片野広之, 間瀬光人. 手術の実際と工夫 : 壁縫合・止血. 遠藤俊郎, 永田泉編. 頚動脈内膜剥離術プラクティス : CEAの根拠とスキルがわかる決定版, メディカ出版, 大阪, 2013, p166-71.
 
9) 上山憲司, 村橋威夫. 頚動脈内膜剥離術におけるヘマシールドパッチグラフトを使用した血管縫合法. 脳外速報. 2013 ; 23 : 503-9.
Medical*Online
P.196 掲載の参考文献
1) 日本脳卒中学会 脳卒中ガイドライン委員会編. 頚動脈内膜剥離術 (carotid endarterectomy : CEA). 脳卒中治療ガイドライン 2015, 協和企画, 東京, 2015, p127-30.
 
2) 日本脳神経外科学会資料. CEAとCASの手術件数の年次推移. 2016.
 
3) Eckstein HH, Schmidli J, Schumacher H, et al. Rationale, scope, and 20-year experience of vascular surgical training with lifelike pulsatile flow models. J Vasc Surg. 2013 ; 1422-8.
PubMed
4) Duschek N, Assadian A, Lamont PM, et al. Simulator training on pulsatile vascular models significantly improves surgical skills and the quality of carotid patch plasty. J Vasc Surg. 2013 ; 57 : 1148-54.
PubMed
5) Belykh EG, Lei T, Oliveira MM, et al. Carotid Endarterectomy Surgical Simulation Model Using a Bovine Placenta Vessel. Neurosurgery. 2015 ; 77 : 825-30.
PubMed
6) 宇野昌明. 疑似血管と簡易型回路によるCEAの練習モデルの開発. 脳卒中の外科. 2013 ; 41 : 143-7.
Medical*Online
7) 宇野昌明. 頸動脈内膜剥離術に関する教育の重要性と今後の方向. MEDICAL TOURCH. 2015 ; 1 : 10-9, 22-3.
 
8) 印東雅大, 堤一生. 実践に活かす基本テクニック訓練. これからの脳神経外科・形成外科医のための顕微鏡手術の技法超入門. 2009, p24-44.
 
9) 堤一生. 私の手術教育. 初心者指導の経験から. 脳卒中の外科. 2007 ; 35 : 361-3.
 
10) Black SA, Pandey VA, Wolfe JH. Training for carotid intervention : preparing the next generation. Eur J Vasc Endovasc Surg. 2007 ; 33 : 518-24.
PubMed
P.207 掲載の参考文献
1) Bademci G, Yasargil MG. Microsurgical anatomy of the hypoglossal nerve. J Clin Neurosci. 2006 ; 13 : 841-7.
PubMed
2) Bejjani GK, Sullivan B, et al. Surgical Anatomy of the Infratemporal Fossa : The Styloid Diaphragm Revisited. Neurosurgery. 1998 ; 43 : 842-53.
PubMed
3) Beretta F, Hemida SA, et al. Exposure of the cervical internal carotid artery : surgical steps to the cranial base and morphometric study. Neurosurgery. 2006 ; 59 : 25-34.
 
4) Kubota H, Sanada Y, et al. Surgical accessibility of the distal internal carotid artery on carotid endarterectomy evaluated using magnetic resonance angiography. Neurosurgery. 2015 ; 76 : 633-6.
PubMed
5) 遠藤俊郎, 林央周, 他. シャントシステムを用いないCEA. No Shinkei Geka. 2001 ; 29 : 605-15.
 
6) 鳴海治, 吉田和道, 他. 高位内頚動脈狭窄病変に対する頚動脈内膜剥離術における解剖に基づいた手術手技の工夫-Styloid Diaphragmの解剖を中心に-. 脳卒中の外科. 2010 ; 38 : 380-6.
Medical*Online
7) 鳴海治, 吉田和道, 他. 頚動脈内膜剥離術における解剖に基づいた手術手技の工夫-皮下組織と耳下腺の剥離-. 脳卒中の外科. 2013 ; 41 : 96-101.
Medical*Online
8) 林央周, 堀恵美子, 他. 高位頸動脈狭窄病変に対する頸動脈血栓内膜剥離術の問題点と手術手技. 脳卒中の外科. 2008 ; 36 : 163-7.
Medical*Online
9) 原貴行, 水谷徹, 他. 頸部頸動脈狭窄症に対する頸動脈内膜剥離術-安全な手術を目指して工夫していること-. 脳卒中の外科. 2008 ; 36 : 355-60.
 
P.213 掲載の参考文献
1) Brott TG, Halperin JL, et al. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Ver tebral Ar tery Disease. Circulation. 2011 ; 124 : e54-130.
 
2) Gailloud P, Murphy KJ, et al. Bilateral thoracic bifurcation of the common carotid artery associated with Klippel-Feil anomaly. AJNR Am J Neuroradiol. 2000 ; 21 : 941-4.
PubMed
3) Gillon J, Schechter S, et al. Horner's Syndrome : A Complication Following Carotid Endarterectomy-A Case Report. Vasc Endovasc Surg. 1993 ; 27 : 296-302.
 
4) Massey EW, Heyman A, et al. Cranial ner ve paralysis following carotid endarterectomy. Stroke. 1984 ; 15 : 157-9.
 
5) Coady MA, Adler F, et al. Nonrecurrent laryngeal nerve during carotid artery surgery : case report and literature review. J Vasc Surg. 2000 ; 32 : 192-6.
PubMed
6) Park JK, Jeong SY, et al. Variations in the course of the cervical vagus nerve on thyroid ultrasonography. AJNR Am J Neuroradiol. 2011 ; 32 : 1178-81.
PubMed
7) Lanzer P, Topol EJ (ed). Chapter 99 : Supra-aortic great vessels : Surgical and Percutaenous approach. PanVascular Medicine. Springer Verlag, Tokyo, 2002, p1584-7.
 
8) Linni K, Aspalter M, et al. Proximal common carotid artery lesions : endovascular and open repair. Eur J Vasc Endovasc Surg. 2011 ; 41 : 728-34.
PubMed
9) Clair DG, Greenberg RK. Diagnosis and treatment of proximal carotid lesions. Semin Vasc Surg. 2000 ; 13 : 103-8.
PubMed
10) De Bakey ME, Crawford ES, et al. Surgical considerations of occlusive disease of innominate, carotid, subclavian, and vertebral arteries. Ann Surg. 1959 ; 149 : 690-710.
PubMed
11) De Bakey ME, Crawford ES, et al. Surgical treatment of patients with cerebral arterial insufficiency associated with extracranial arterial occlusive lesions. Neurology. 1961 ; 11 : 145-9.
 
12) Crawford ES, De Bakey ME, et al. Thrombo-obliterative disease of the great vessels arising from the aortic arch. J Thorac Cardiovasc Surg. 1962 ; 43 : 38-53.
PubMed
13) Crawford ES, De Bakey ME, et al. Surgical treatment of occlusion of the innominate, common carotid, and subclavian arteries : a 10 year experience. Surgery. 1969 ; 65 : 17-31.
PubMed
14) Berguer R, Morasch MD, et al. Cervical reconstruction of the supra-aortic trunks : a 16-year experience. J Vasc Surg, 1999 ; 29 : 239-46.
PubMed
15) Bachman DM, Kim RM. Transluminal dilatation for subclavian steal syndrome. Am J Roentgenol. 1980 ; 135 : 995-6.
 
16) Mathias K, Schlosser V, et al. Katheterrekanalisation eines Subklaviaverschlusses. RoFo. 1980 ; 132 : 346-7.
PubMed
17) Queral LA, Criado FJ. The treatment of focal aortic arch branch lesions with Palmaz stents. J Vasc Surg. 1996 ; 23 : 368-75.
PubMed
18) Kikuchi T, Ishii A, et al. Japanese Registry of Neuroendovascular Therapy : extracranial steno-occlusive diseases except for internal carotid artery stenosis. Neurol Med Chir (Tokyo). 2014 ; 54 : 40-5.
 
19) Diethrich EB, Marx P, et al. Percutaneous techniques for endoluminal carotid interventions. J Endovasc Surg. 1996 ; 3 : 182-202.
PubMed
20) Nakahara I, Higashi T, et al. Intraoperative stenting for brachiocephalic and carotid artery stenosis. Neurosurgery. 2010 ; 66 : 876-82.
PubMed
21) Sfyroeras GS, Karathanos C, et al. A meta-analysis of combined endarterectomy and proximal balloon angioplasty for tandem disease of the arch vessels and carotid bifurcation. J Vasc Surg. 2011 ; 54 : 534-40.
PubMed
22) Georg Y, Psathas E, et al. Double eversion carotid endarterectomy of tandem carotid lesions. Ann Vasc Surg. 2014 ; 28 : 1186-91.
PubMed
23) Aguiar ET, Lederman A, et al. Ring-stripping retrograde common carotid endarterectomy : case report. Sao Paulo Med J. 2002 ; 120 : 154-7.
PubMed
24) Hertzer NR, Feldman BJ, et al. A prospective study of the incidence of injury to the cranial nerves during carotid endarterectomy. Surg, Gynecol and Obstet. 1980 ; 151 : 781-4.
 
25) Hye RJ, Mackey A, et al. Incidence, outcomes, and effect on quality of life of cranial ner ve injury in the Carotid Revascularization Endarterectomy versus Stenting Trial. J Vasc Surg. 2015 ; 61 : 1208-14.
 
26) 永田泉. 頸動脈内膜剥離術の実際-Patch法-. 日外会誌. 2011 ; 112 : 390-3.
 
P.220 掲載の参考文献
1) Lippman HH, Sundt TM Jr, Holman CB. The poststenotic carotid slim sign : spurious internal carotid hypolasia. Mayo Clin Proc. 1970 ; 45 (11) : 762-7.
PubMed
2) Sekhar LN, Heros RC, Lotz PR, et al. Atheromatous pseudoocclusion of the internal carotid artery. J Neurosurg. 1980 ; 52 (6) : 782-9.
PubMed
3) 吉田和道, 鳴海治, 沈正樹, 他. Near Occlusionに対するCarotid Endarterectomy-MRIプラーク性状評価と術後内頸動脈の開存性について-. 脳卒中の外科. 2007 ; 35 : 281-8.
 
4) Hirata Y, Sakata N, Inoue T, et al. Histopathological features with angiographic correlates of internal carotid artery pseudo-occlusion : impact of plaque compositions. Clinical article. J Neurosurg. 2011 ; 115 (2) : 350-8.
PubMed
5) Okawa M, Abe H, Ueba T, et al. Identification of plaque location using indocyanine green videoangiography during carotid endarterectomy. Acta Neurochir. 2014 ; 119 : 97-101.
PubMed
6) Morgenstern LB, Fox AJ, Sharpe BL, et al. The risks and benefits of carotid endarterectomy in patients with near occlusion of the carotid artery. Nor th American Symptomatic Carotid Endarterectomy Trial (NASCET) Group. Neurology. 1997 ; 48 : 911-5.
 
7) Kishikawa K, Kamouchi M, Okada Y, et al. Transoral carotid ultrasonography as a diagnostic aid in patients with severe carotid stenosis. Cerebrovasc Dis. 2004 ; 17 (2-3) : 106-10.
 
8) 林央周, 堀恵美子, 桑山直也, 他. 頸部内頸動脈偽閉塞症の病態と頸動脈内膜剥離術の妥当性. 脳卒中の外科. 2005 ; 33 : 187-92.
 
9) 卯田健, 井上享, 一ツ松勤, 他. Tandem lesionを伴う内頸動脈狭窄病変に対する血行再建術. No Shinkei Geka. 2003 ; 31 : 63-7.
 
10) Greiner C, Wassmann H, Palkovic S, et al. Revascularization procedures in internal carotid artery pseudo-occlusion. Acta Neurochir (Wien). 2004 ; 146 (3) : 237-43.
PubMed
11) 卯田健, 井上享, 藤本茂, 他. 頸動脈内膜剥離術後に過灌流症候群を呈した一例-術後脳循環評価と周術期管理について-. 脳外誌. 2003 ; 12 : 695-700.
 
P.226 掲載の参考文献
1) Harrison MJ, et al. The finding of thrombus at carotid endarterectomy and its relationship to the timing of surgery. Br J Surg. 1977 ; 64 : 511-2.
 
2) Mommertz G, et al. Early control of distal internal carotid artery during carotid endarterectomy : does it reduce cerebral microemboli? J Cardiovasc Surg (Torino). 2010 ; 51 : 369-75.
PubMed
3) Naylor AR. Occam's razor : Intervene early to prevent more strokes! J Vasc Surg. 2008 ; 48 : 1053-9.
PubMed
4) Pratesi C, et al. Reducing the risk of intraoperative neurological complications during carotid endarterectomy with early distal control of the internal carotid artery. Eur J Vasc Endovasc Surg. 2004 ; 28 : 670-3.
PubMed
5) Rantner B, et al. Very urgent carotid endarterectomy does not increase the procedural risk. Eur J Vasc Endovasc Surg. 2015 ; 49 : 129-36.
 
6) Rockman CB, et al. Early carotid endarterectomy in symptomatic patients is associated with poorer perioperative outcomes. J Vasc Surg. 2006 ; 44 : 480-7.
PubMed
7) Rothwell PM, et al. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet. 2004 ; 363 : 915-24.
PubMed
8) Wolf O, et al. Microembolic signals detected by transcranial Doppler sonography during carotid endarterectomy and correlation with serial diffusion-weighted imaging. Stroke. 2004 ; 35 : e373-5.
PubMed
9) Yoshida K, et al. Surgical dissection of the internal carotid artery under flow control by proximal vessel clamping reduces embolic infarcts during carotid endarterectomy. World Neurosurg. 2014 ; 82 : e229-34.
PubMed
P.233 掲載の参考文献
1) Yadav JS, Wholey MH, Kuntz RE, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. New Engl J Med. 2004 ; 351 : 1493-501.
PubMed
2) Fokkema M, den Har tog AG, Bots ML, et al. Stenting versus surgery in patients with carotid stenosis after previous cervical radiation therapy : Systematic review and meta-analysis. Stroke. 2012 ; 43 : 793-801.
 
3) Tallarita T, Oderich GS, Lanzino G, et al. Outcomes of carotid artery stenting versus historical surgical controls for radiation-induced carotid stenosis. Journal of vascular surgery 2011 ; 53 : 629-36, e621-5.
 
4) Sano N, Satow T, Maruyama D, et al. Relationship between histologic features and outcomes of carotid revascularization for radiation-induced stenosis. J Vasc Surg. 2015 ; 62 : 370-7, e371.
 
5) Gujral DM, Shah BN, Chahal NS, et al. Clinical features of radiation-induced carotid atherosclerosis. Clin Oncol. 2014 ; 26 : 94-102.
PubMed
6) Protack CD, Bakken AM, Saad WE, et al. Radiation arteritis : A contraindication to carotid stenting? J Vasc Surg. 2007 ; 45 : 110-7.
PubMed
7) Iihara K, Satow T, Matsushige T, et al. Hybrid operating room for the treatment of complex neurovascular and brachiocephalic lesions. J Stroke Cerebrovasc Dis. 2013 ; 22 : e277-85.
PubMed
8) Rockman CB, Riles TS, Fisher FS, et al. The surgical management of carotid artery stenosis in patients with previous neck irradiation. Am J Surg. 1996 ; 172 : 191-5.
PubMed
P.248 掲載の参考文献
1) 宿澤孝太, 墨誠, 金岡祐司, 他. 脳梗塞ゼロを実現した慈大式小切開Eversion内膜剥離術. 日外会誌. 2011 ; 112 : 394-8.
 
2) Ohki T. Enhancing carotid endarterectomy like its inter ventional counterpart, open surgical carotid revascularization has also seen technical improvements, including the mini-incision Jikei method. Endovascular Today. 2012 ; 10 : 68-77.
 
3) 金岡祐司, 大木隆生. CEA手術の実際 3-F CEAのすべてEversion法の使用. 頚動脈内膜剥離プラクティス, メディカ出版, 大阪, 2013, p191-201.
 
4) Mehta M, Rahmani O, Dietzek AM, Ohki T, Veith FJ. Eversion technique increases the risk for post-carotid endarterectomy hypertension. J Vasc Surg. 2001 ; 34 : 839-45.
PubMed
5) Ohki T. A preview of today's new products. OHKI baum, venous forceps, and OHKI tunneler. Endovascular Today. 2015 ; 8 : 90.
 
P.253 掲載の参考文献
1) 宇野昌明, 鈴江淳彦, 他. 冠動脈疾患合併に対するCEA-自験例と文献的考察-. Jpn J Neurosurg (Tokyo). 2003 ; 12 : 723-8.
 
2) Brott TG, Hobson RW, et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. New Engl J Med. 2010 ; 363 : 11-23.
PubMed
3) Sudhakaran S, Surani SR. Guidelines for Perioperative Management of the Diabetic Patient. Surg Res Prac. 2015 ; 2015 : 284063.
 
4) Mangram AJ, Horan TC, et al. Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infec Control. 1999 ; 27 : 97-132.
 
5) Ling Y, Li X, et al. Intensive versus conventional glucose control in critically ill patients : a meta-analysis of randomized controlled trials. Eur J Intern Med. 2012 ; 23 : 564-74.
PubMed
6) Anderson DJ, Podgorny K, et al. Strategies to prevent surgical site infections in acute care hospitals : 2014 update. Infec Control Hosp Epidemiol. 2014 ; 35 : 605-27.
 
P.261 掲載の参考文献
1) Silver FL, Mackey A, et al. Safety of stenting and endarterectomy by symptomatic status in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST). Stroke. 2011 ; 42 : 675-80.
PubMed
2) 安部洋, 井上亨. CEAの手術手技. NS NOW 6 脳虚血の外科, メジカルビュー社, 東京, 2009, p95-102.
 
3) 一ツ松勤. 頚動脈内膜剥離術における脳・頚神経損傷の回避-外科解剖と手術手技-. No Shinkei Geka. 2014 ; 42 : 817-28.
 
4) 一ツ松勤, 西村中, 他. CEA術後脳神経麻痺合併の回避 : 自験連続216例の検討. 脳卒中の外科. 2015 ; 43 : 165-74.
Medical*Online
5) 一ツ松勤. 頚動脈内膜剥離術 ; 手術の実際と合併症回避のコツ. 脳神経外科診療プラクティス 5 無症候性脳血管障害を解く, 文光堂, 東京, 2015, p214-8.
 
6) Ling XY, Smoll NR. A systematic review of variations of the recurrent laryngeal nerve. Clin Anat. 2016 ; 29 : 104-10.
PubMed
7) Coady MA, Adler F, et al. Nonrecurrent laryngeal nerve during carotid artery surgery : case report and literature review. J Vasc Surg. 2000 ; 32 : 192-6.
PubMed
P.267 掲載の参考文献
1) Sundt TM Jr, et al. Correlation of cerebral blood flow and electroencephalographic changes during carotid endarterectomy : with results of surgery and hemodynamics of cerebral ischemia. Mayo Clin Proc. 1981 ; 56 (9) : 533-43.
PubMed
2) Hosoda K, et al. Cerebral vasoreactivity and internal carotid artery flow help to identify patients at risk for hyperperfusion after carotid endarterectomy. Stroke. 2001 ; 32 (7) : 1567-73.
PubMed
3) Moulakakis KG, et al. Hyperperfusion syndrome after carotid revascularization. J Vasc Surg. 2009 ; 49 (4) : 1060-8.
PubMed
4) Ogasawara K, et al. Intracranial hemorrhage associated with cerebral hyperperfusion syndrome following carotid endarterectomy and carotid artery stenting : retrospective review of 4494 patients. J Neurosurg. 2007 ; 107 (6) : 1130-6.
PubMed
5) van Mook WN, et al. Cerebral hyperperfusion syndrome. Lancet Neurol. 2005 ; 4 (12) : 877-88.
PubMed
6) Ogasawara K, et al. Postoperative cerebral hyperperfusion associated with impaired cognitive function in patients undergoing carotid endarterectomy. J Neurosurg. 2005 ; 102 (1) : 38-44.
PubMed
7) Ogasawara K, et al. Pretreatment with the free radical scavenger edaravone prevents cerebral hyperperfusion after carotid endarterectomy. Neurosurgery. 2004 ; 55 (5) : 1060-7.
PubMed
8) Bouri S, et al. Hyper tension and the post-carotid endarterectomy cerebral hyperperfusion syndrome. Eur J Vasc Endovasc Surg. 2011 ; 41 (2) : 229-37.
 
9) Kawamata T, et al. Postcarotid endarterectomy cerebral hyperper fusion can be prevented by minimizing intraoperative cerebral ischemia and strict postoperative blood pressure control under continuous sedation. Neurosurgery. 2009 ; 64 (3) : 447-53 ; discussion 453-4.
 
10) Fujimoto S, et al. Diagnostic impact of transcranial colorcoded real-time sonography with echo contrast agents for hyperperfusion syndrome after carotid endarterectomy. Stroke. 2004 ; 35 (8) : 1852-6.
PubMed
P.272 掲載の参考文献
1) 日本脳神経超音波学会・栓子検出と治療学会合同ガイドライン作成委員会. 頸部血管超音波検査ガイドライン. Neurosonology. 2006 ; 19 : 48-67.
 
2) Tu J, Wang S, Huo Z, et al. Repeated carotid endarterectomy versus carotid artery stenting for patients with carotid restenosis after carotid endarterectomy : Systematic review and meta-analysis. Surgery. 2015 ; 157 : 1166-73.
PubMed
3) 桑山直也, 遠藤俊郎, JCASグループ. 本邦における頚動脈の前向き登録 (jcas研究). 脈管学. 2010 ; 50 : 723-7.
 
4) Stoney RJ, String ST. Recurrent carotid stenosis. Surgery. 1976 ; 80 : 705-10.
PubMed
5) De Borst GJ, Moll F. Biology and treatment of recurrent carotid stenosis. J Cardiovasc Surg (Torino). 2012 ; 53 : 27-34.
PubMed
6) Carballo RE, Towne JB, Seabrook GR, et al. An outcome analysis of carotid endarterectomy : The incidence and natural history of recurrent stenosis. J Vasc Surg. 1996 ; 23 : 749-53 ; discussion 753-44.
 
7) AbuRahma AF, Robinson PA, Stickler DL. Analysis of regression of postoperative carotid stenosis from prospective randomized trial of carotid endarterectomy comparing primary closure versus patching. Ann Surg. 1999 ; 229 : 767-72 ; discussion 772-63.
 
8) Bekelis K, Moses Z, Missios S, et al. Indications for treatment of recurrent carotid stenosis. Br J Surg. 2013 ; 100 : 440-7.
PubMed
9) 中嶋千也, 大西英之, 垰本勝司, 他. 頚動脈血栓内膜剥離術 (CEA) 後の再狭窄についての検討-シロスタゾールは再狭窄の予防に有効か-. 脳卒中の外科. 2010 ; 38 : 110-3.
Medical*Online

IV 外科的治療 (2) : 頚動脈ステント留置術 ( CAS )

P.280 掲載の参考文献
1) Brott TG, Hobson RW 2 nd, Howard G, et al. CREST Investigators. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010 ; 363 (1) : 11-23.
 
2) Yadav JS, Wholey MH, Kuntz RE, et al. Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy Investigators. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004 ; 351 (15) : 1493-501.
PubMed
3) 許俊鋭, 他. 非心臓手術における合併心疾患の評価と管理に関するガイドライン 2014 (2012-2013年度合同研究班報告). p6, 表3.
 
4) 許俊鋭, 他. 非心臓手術における合併心疾患の評価と管理に関するガイドライン 2014 (2012-2013年度合同研究班報告). p6, 表4, 5.
 
5) 伊刈裕二. 4. 全身評価 (心臓, 大動脈, 末梢, 腎臓). 頚動脈狭窄症の診療とステント留置術の実際, 坂井信幸 (編), 永井書店, 大阪, 2011, p136-47.
 
6) 讃岐美智. やさしくわかる麻酔科研修. 秀潤社, 東京, 2015, p241.
 
7) 大北裕, 他. 弁膜疾患の非薬物治療に関するガイドライン. 循環器病の診断と治療に関するガイドライン (2012年改訂版), 2011年度合同研究班報告, p20, 図5.
 
8) 大野岩男, 他. 腎障害患者におけるヨード造影剤使用に関するガイドライン 2012. 東京医学社, 東京, 2013, p3-5.
 
9) 大野岩男, 他. 腎障害患者におけるヨード造影剤使用に関するガイドライン 2012. 東京医学社, 東京, 2013, p33-5.
 
10) 大野岩男, 他. 腎障害患者におけるヨード造影剤使用に関するガイドライン 2012. 東京医学社, 東京, 2013, p50-1.
 
11) 大野岩男, 他. 腎障害患者におけるヨード造影剤使用に関するガイドライン 2012. 東京医学社, 東京, 2013, p34.
 
12) 大野岩男, 他. 腎障害患者におけるヨード造影剤使用に関するガイドライン 2012. 東京医学社, 東京, 2013, p8-9.
 
13) 大野岩男, 他. 腎障害患者におけるヨード造影剤使用に関するガイドライン 2012.東京医学社, 東京, 2013, p36-7.
 
14) 讃岐美智. やさしくわかる麻酔科研修. 秀潤社, 東京, 2015, p240.
 
15) 稲田栄一. 麻酔への知的アプローチ第9版. 日本薬事新報社, 東京, 2015, p54.
 
16) 稲田栄一. 麻酔への知的アプローチ 第9版. 日本薬事新報社, 東京, 2015, p46-7.
 
17) 大野岩男, 他. 腎障害患者におけるヨード造影剤使用に関するガイドライン 2012. 東京医学社, 東京, 2013, p9-11.
 
18) Huibers A, Halliday A, Bulbulia R, et al ; ACST-2 Collaborative Group. Antiplatelet therapy in carotid artery stenting and carotid endarterectomy in the Asymptomatic Carotid Surgery Trial-2. Eur J Vasc Endovasc Surg. 2016 Mar ; 51 (3) : 336-42.
 
19) Delgado Almandoz JE, Crandall BM, Scholz JM, et al. Variability in initial response to standard clopidogrel therapy, delayed conversion to clopidogrel hyper-response, and associated thromboembolic and hemorrhagic complications with cerebral aneurysms treated with the Pipeline Embolization Device. J Neurointerv Surg. 2013 ; 5 Suppl 3 : iii3-10.
 
20) Nishi H, Nakahara I, Matsumoto S, et al. Platelet reactivity and hemorrhage risk in neurointerventional procedures under dual antiplatelet therapy. J Neurointerv Surg. 2015 ; pii : neurintsurg-2015-011844.
 
21) Jeong YH. "East asian paradox" : challenge for the current antiplatelet strategy of "one-guideline-fits-all races" in acute coronary syndrome. Curr Cardiol Rep. 2014 ; 16 : 485.
PubMed
P.287 掲載の参考文献
1) Chaturvedi S, Sohrab S, et al. Carotid stent thrombosis : report of 2 fatal cases. Stroke. 2007 ; 32 : 2700-2.
 
2) McKevitt FM, Randall MS, et al. The benefits of combined anti-platelet treatment in carotid artery stenting. Eur J Vasc Endovasc Surg. 2005 ; 29 : 522-7.
PubMed
3) Bates ER, Babb JD, et al. American College of Cardiology Foundation Task Force ; American Society of Interventional & Therapeutic Neuroradiology; Society for Cardiovascular Angiography and Inter ventions ; Society for Vascular Medicine and Biology; Society for Interventional Radiology. ACCF/SCAI/SVMB/SIR/ASITN 2007 Clinical Expert Consensus Document on carotid stenting. Vasc Med. 2007 ; 12 : 35-83.
 
4) Delgado ALmandoz JE, et al. Last-recorded P2Y12 reaction units value is strongly associated with thromboembolic and hemorrhagic complications occurring up to 6 months after treatment in patients with cerebral aneurysms treated with the pipeline embolization device. AJNR Am J Neuroradiol. 2014 ; 35 : 128-35.
PubMed
5) Kims IS, Jeong YH, et al. Correlation of high post-treatment reactivity assessed by light transmittance aggregometry and the VerifyNow P2 Y12 assay. J Thromb Thrombolysis. 2010 ; 30 : 436-95.
 
6) Chen WH, Lee PY, et al. Aspirin resistance is associated with a high incidence of myonecrosis after percu- taneous coronary intervention despite clopidogrel pretreatment. J Am Coll Cardiol. 2004 ; 43 : 1122-6.
 
7) Stone GW, et al. for the ADAPT-DES investigators. Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES) : a prospective multicentre registry study. Lancet. 2013 ; 382 : 614-23.
PubMed
8) Prince MJ, Berger PB, et al. Standard- vs. high-dose clopidogrel based on platelet function testing after percutaneous coronary inter ventions : the GRAVITAS randomized trial. JAMA. 2011 ; 305 : 1097-105.
 
9) Ono T, Kakita K, et al. Determination of cut-off levels for on-clopidogrel platelet aggregation based on functional CYP2 C19 gene variants in patients undergoing elective percutaneous coronary intervention. Thromb Res. 2011 ; 128 : e130-6.
 
10) 榎本由貴子, 吉村紳一, 他. 緊急脳血管内治療時における抗血小板薬loading dose投与後の薬効解析. JNET. 2014 ; 8 : 251-8.
Medical*Online
11) Fukushima-Uesaka H, Sai K, Maekawa K, et al. Genetic variations and haplotypes of CYP2 C19 in a Japanese population. Drug Metab Pharmacokinet. 2005 ; 20 : 300-7.
 
12) Bangalore S, Singh A, et al. Efficacy of cilostazol on platelet reactivity and cardiovascular outcome in patients undergoing percutaneous coronary intervention : insights from a meta-analysis of randomized trials. Open Heart. 2014 ; 1 : e000068.
PubMed
13) Fiti JT, Brockington C, et al. Clopidogrel resistance is associated with thromboembolic complications in patients undergoing neurovascular stenting. AJNR Am J Neuroradiol. 2013 ; 34 : 716-20.
 
14) Li J, Jian Z, et al. Tailored antiplatelet therapy and clinical adverse outcomes. Heart. 2014 ; 100 : 41-6.
 
P.293 掲載の参考文献
1) Stone GW, Witzenbichler B, Weisz G, et al. Platelet reactivity and clinical outcomes after coronary implantation of drug-eluting stents (ADAPT-DES) : a prospective multicentre registry study. Lancet. 2013 ; 382 (9892) : 614-23.
PubMed
2) Nakamura M, Isshiki T, Kimura T, et al. Int J Cardiol. 2015 ; 182 : 541-8.
PubMed
3) Gurbel PA, Tantry US. Clopidogrel resistance? Thromb Res. 2007 ; 120 : 311-21.
PubMed
4) Furuta T, Shirai N, Sugimoto M, et al. Influence of CYP2 C19 pharmacogenetic polymorphism on proton pump inhibitor-based therapies. Drug Metab. Pharmacokinet. 2005 ; 20 (3) : 153-67.
 
5) Brar SS, ten Berg J, Marcucci R, et al. Impact of platelet reactivity on clinical outcomes after percutaneous coronary inter vention. A collaborative meta-analysis of individual participant data. J Am Coll Cardiol. 2011 ; 58 (19) : 1945-54.
 
6) Nishio R1, Shinke T, Otake H, et al. Effect of cytochrome P450 2C19 polymorphism on target lesion outcome after drug-eluting stent implantation in japanese patients receiving clopidogrel. Circ J. 2012 ; 76 (10) : 2348-55.
 
7) Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007 ; 357 : 2001-15.
PubMed
8) Isshiki T, Kimura T, Ogawa H, et al. Prasugrel, a third-generation P2 Y12 receptor antagonist, in patients with coronary artery disease undergoing elective percutaneous coronary intervention. Circ J. 2014 ; 78 : 2926-34.
 
P.299 掲載の参考文献
1) McCulloch TJ, Thompson CL, Turner MJ. A randomized crossover comparison of the effects of propofol and sevoflurane on cerebral hemodynamics during carotid endarterectomy. Anesthesiology. 2007 ; 106 (1) : 56-64.
 
2) Moritz S, Kasprzak P, Arlt M, et al. Accuracy of cerebral monitoring in detecting cerebral ischemia during carotid endarterectomy : a comparison of transcranial Doppler sonography, near-infrared spectroscopy, stump pressure, and somatosensory evoked potentials. Anesthesiology. 2007 ; 107 (4) : 563-9.
PubMed
3) Matsumoto S, Nakahara I, Higashi T, et al. Near-infrared spectroscopy in carotid artery stenting predicts cerebral hyperperfusion syndrome. Neurology. 2009 ; 72 (17) : 1512-8.
PubMed
P.311 掲載の参考文献
1) Miyachi S, Sakai N, et al. Historical perspective of carotid artery stenting in Japan : Analysis of 8092 cases in the Japanese CAS survey. Acta Neurochir. 2012 ; 154 : 2127-37.
 
2) Kim SJ, Roh HG, et al. Cerebral ischemia detected with diffusion-weighted MR imaging after protected carotid artery stenting : Comparison of distal balloon and filter device. Korean J Radiol. 2007 ; 8 : 276-85.
PubMed
3) Zahn R, Ischinger T, et al. Embolic protection devices for carotid artery stenting : is there a difference between filter and distal occlusive devices? J Am Coll Cardiol. 2005 ; 45 : 1769-74.
 
4) 中原一郎. 頚動脈ステント留置術Carotid Artery Stenting (CAS) のすべて, メジカルビュー社, 東京, 2008.
 
5) 石井暁. 脳血管内治療の基本手技.「超」入門脳血管内治療, メディカ出版, 大阪, 2012.
 
6) 石橋良太, 中原一郎, 他. 頚動脈ステント留置術の基本. Jpn Intervent Radiol. 2013 ; 28 : 28-36.
 
7) 山本章貴, 滝和郎. 頚動脈・頭蓋内ステント : 現状と展望. ICUとCCU. 2012 ; 36 : 699-706.
 
8) Shinozaki N, Ikari Y, et al. Plaque protrusion detected by intravascular ultrasound during carotid artery stenting. J Stroke Cerebrovasc Dis. 2014 ; 23 : 2622-5.
PubMed
P.314 掲載の参考文献
1) J-CASES (Japan Carotid Artery Stent Education System) : http://jcases.wbt.ne.jp/
 
2) EVE EndoVascular Evaluator : http://fain-biomedical.com/
 
3) Circuit Trinity : http://www.justmedical.jp/
 
4) Mentice VIST : http://www.mentice.com/
 
5) ANGIO Mentor : http://www.simbionix.com/
 
6) Cath Lab VR : http://www.caehealthcare.com/
 
7) 入江恵子, 中居康展, 中原一郎, 他. 脳動脈瘤コイル塞栓術におけるコンピューターシミュレーター (VIST) を用いた技能分析. JNET. 201 ; 6 : 252-7.
 
8) Ahmed K, Keeling AN, Fakhry M, et al. Role of virtual reality simulation in teaching and assessing technical skills in endovascular intervention. J Vasc Interv Radiol. 2010 ; 21 : 55-66.
PubMed
9) Hsu JH, Younan D, Pandalai S, et al. Use of computer simulation for determining endovascular skill levels in a carotid stenting model. J Vasc Surg. 2004 ; 40 : 1118-25.
 
10) 関連11学会承認 頚動脈ステント留置術実施基準 (2012年1月改訂) : http://www.jsnet.umin.jp/sozai/info-device/120117cas.pdf
 
11) Gould DA, Kessel DO, Healey AE, et al. Simulators in catheter-based inter ventional radiology : training or computer games? Clinical Radiology. 2006 ; 61 : 556-61
PubMed
P.323 掲載の参考文献
1) Setacci C, Chisci E, et al. Siena carotid artery stenting score : a risk modelling study for individual patients. Stroke. 2010 ; 41 : 1259-65.
 
2) Fanous AA, Natarajan SK, et al. High-Risk Factors in Symptomatic Patients Undergoing Carotid Artery Stenting With Distal Protection : Buffalo Risk Assessment Scale (BRASS). Neurosurgery. 2015 ; 77 : 531-42.
PubMed
3) Madhwal S, Rajagopal V, et al. Predictors of difficult carotid stenting as determined by aortic arch angiography. J Invasive Cardiol. 2008 ; 20 : 200-4.
PubMed
4) Faggioli GL, Ferri M, et al. Aortic arch anomalies are associated with increased risk of neurological events in carotid stent procedures. Eur J Vas Endvasc Surg. 2007 ; 33 : 436-41.
 
5) Shaw JA, Gravereaux EC, et al. Carotid stenting in the bovine arch. Cardiovasc Interv. 2003 ; 60 : 566-9.
PubMed
6) Kizilkilic O. Vertebral artery origin stenting with buddy wire technique in tortuous subclavian artery. Eur J Radiol. 2007 ; 61 : 120-3.
PubMed
7) 見崎孝一, 内山尚之, 他. 左総頚動脈ステント留置術におけるガイディングシース保持のためのGooseNeck Snareの使用. JNET. 2012 ; 6 : 56-60.
Medical*Online
8) 松本博之, 増尾修, 他. 経上腕アプローチによる頚動脈ステント留置術. JNET. 2007 ; 1 : 40-4.
 
9) 高下純平, 中原一郎, 他. バルーン付きガイディングカテーテルを用いた経上腕動脈アプローチによるproximal balloon protection下の頚動脈ステント留置術 : 9Fr Optimoを用いたシースレス法. JNET. 2015 ; 9 : 108-14.
Medical*Online
10) 早川幹人, 滝川知司, 他. 経橈骨動脈アプローチによる頚動脈ステント留置術. JNET. 2012 ; 6 : 16-24.
Medical*Online
11) 松本博之, 藤田浩二, 他. 小切開による頚動脈直接穿刺により頚動脈ステントを留置した1例. No Shinkei Geka. 2004 ; 32 : 735-40.
 
P.329 掲載の参考文献
1) 松本博之, 増尾修, 武本英樹, 他. 経上腕アプローチによる頸動脈ステント留置術. JNET. 2007 ; 1 : 40-4.
Medical*Online
2) Al-Mubarak N, Vitek JJ, Iyer SS, et al. Carotid stenting with distal-balloon protection via the transbrachial approach. J Endovasc Ther. 2001 ; 8 : 571-5.
PubMed
3) 原口浩一, 外山賢太郎, 永井真理子, 他. 経橈骨動脈アプローチによる頚動脈ステント留置術. JNET. 2012 ; 6 : 209-13.
Medical*Online
4) 早川幹人, 滝川知司, 神谷雄己, 他. 経橈骨動脈アプローチによる頚動脈ステント留置術. JNET. 2012 ; 6 : 16-24.
Medical*Online
5) Iwata T, Mori T, Miyazaki Y, et al. Initial experience of a novel sheath guide for transbrachial carotid artery stenting : technical note. J Neurointervent Surg. 2013 ; 5 : 77-80.
 
6) Montrosi P, Galli S, Ravagnani PM, et al. Carotid artery stenting in patients with left ICA stenosis and bovine aortic arch ; a single-center experience in 60 consecutive patients treated via the right radial or brachial approach. J Endovasc Ther. 2014 ; 21 : 127-36.
PubMed
7) Oomura M, Yamada K, Anan C, et al. Transbrachial carotid artery stenting can prevent renal cholesterol embolism. Intern Med. 2014 ; 53 : 1017-21.
PubMed
8) Folmar J, Sachar R, Mann T, et al. Transradial approach for carotid artery stenting : a feasibility study. Catheter Cardiovasc Interv. 2007 ; 69 : 355-61.
PubMed
9) Kiemeneji F, Laarman GJ, Odekerken D, et al. A randomized comparison of percutaneous transluminal coronary angioplasty by the radial, brachial and femoral approaches : the access. J Am Coll Cardiol. 1997 ; 29 : 1269-75.
 
10) 高下純平, 中原一郎, 太田剛史, 他. バルーン付きガイディングカテーテルを用いた経上腕動脈アプローチによるproximal balloon protection下の頚動脈ステント留置術 : 9 Fr Optimoを用いたシースレス法. JNET. 2015 ; 9 : 108-14.
Medical*Online
11) 高原正樹, 竹本光一郎, 小林広昌, 他. 上腕動脈直接穿刺による経上腕的頚動脈ステント留置術の一例. JNET. 2015 ; 9 : 213-8.
 
12) Pinter L, Cagiannos C, Ruzsa Z, et al. Report on initial experience with transradial access for carotid artery stenting. J Vasc Surg. 2007 ; 45 : 1136-41.
PubMed
P.333 掲載の参考文献
1) Wimmer NJ, Yeh RW, Cutlip DE, et al. Risk prediction for adverse events after carotid artery stenting in higher surgical risk patients. Stroke. 2012 ; 43 : 3218-24.
PubMed
2) Brott TG, Hobson RW, 2nd, Howard G, et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. New Engl J Med. 2010 ; 363 : 11-23.
PubMed
3) Tsutsumi M, Kazekawa K, Onizuka M, et al. Accordion effect during carotid artery stenting : report of two cases and review of the literature. Neuroradiology. 2007 ; 49 : 567-70.
PubMed
P.341 掲載の参考文献
1) Gupta A Baradaran H et al. Carotid plaque MRI and stroke risk. A systemic review and meta-analysis. Stroke. 2013 ; 44 : 3071-77.
 
2) 長束一行. 不安定プラークの概念と診断. Jpn J Neurosurg (Tokyo). 2008 ; 17 : 917-23.
 
3) Kurosaki Y, Yoshida K, et al. Carotid artery plaque assessment using quantitative expansive remodeling evaluation and MRI plaque signal intensity. J Neurosurg. 2015 ; 11. 2016 ; 124 (3) : 736-42
 
4) Yoshimura S, Yamada K, et al. Selection of carotid artery stenting or endarterectomy based on magnetic resonance plaque imaging reduced periprocedural adverse events. J Stroke Cerebrovasc Dis. 2013 ; 22 : 1082-87.
 
5) Biasi GM, Froio A, et al. Carotid plaque echolucency increases the risk of stroke in carotid stenting. The imaging in carotid angioplasty and risk of stroke (ICAROS) study. Circulation. 2004 ; 110 : 756-62.
PubMed
6) Sakamoto S, Kuita Y, et al. Carotid artery stenting for vulnerable plaque on MR angiography and ultrasonography : Utility of dual protection and blood aspiration method. J Neuro Intervent Surg. 2015 ; 0.1-5.
 
7) Bosiers M, Nonato GD, et al. Dose free cell area influence the outcome in carotid artery stenting? Eur J Vasc Endovasc Surg. 2007 ; 33 : 135-41.
 
P.347 掲載の参考文献
1) 循環器病の診断と治療に関するガイドライン (2006-2007年度合同研究班報告). (ダイジェスト版) 血管炎症候群の診療ガイドライン. Circ J. 2008 ; 72, Supple IV : 1319-46.
 
2) 藤井秀毅. PTHの役割. 腎と透析. 2015 ; 79 : 405-9.
Medical*Online
3) 松本省二. 石灰化病変. 頚動脈ステント留置術, メジカルビュー社, 東京, 2008, p238-44.
 
4) Fanous AA, Natarajan SK, et al. High-Risk Factors in Symptomatic Patients Undergoing Carotid Artery Stenting With Distal Protection : Buffalo Risk Assessment Scale (BRASS). Neurosurgery. 2015 ; 77 : 531-42.
PubMed
5) Schneider PA, Kasirajan K. Dif ficult anatomy : what characteristics are critical to good outcomes of either CEA or CAS? Semin Vasc Surg. 2007 ; 20 : 216-25.
PubMed
6) Setacci C, Chisci E, et al. Siena carotid artery stenting score : a risk modelling study for individual patients. Stroke. 2010 ; 41 : 1259-65.
 
P.352 掲載の参考文献
1) Tsutsumi M, Kazekawa K, Tanaka A, et al. Improved cerebral per fusion after simultaneous stenting for tandemstenosis of the internal carotid artery-two case reports. Neurol Med Chir (Tokyo). 2003 ; 43 (8) : 386-90.
 
2) Uda K, Inoue T, Hitotsumatsu T, et al. Vascular reconstruction of tandem stenoses of the internal carotid artery. No Shinkei Geka. 2003 ; 31 (1) : 63-7.
PubMed
3) Cohen JE, Gomori J, Grigoriadis S, et al. Single-staged sequential endovascular stenting in patients with intandem carotid stenoses. Neurol Res. 2008 ; 30 (3) : 262-7. Epub 2007 Sep 27.
 
4) Grego F, Frigatti P, Lepidi S, et al. Synchronous carotid endarterectomy and retrograde endovascular treatment of brachiocephalic or common carotid artery stenosis. Eur J Vasc Endovasc Surg. 2003 ; 26 (4) : 392-5.
PubMed
5) Bazan HA, Sheahan M, Dardik A. Carotid endarterectomy with simultaneous retrograde common carotid artery stenting : technical considerations. Catheter Cardiovasc Interv. 2008 ; 72 (7) : 1003-7. doi : 10.1002/ccd.21730.
 
6) Vermeulen T, Hendriks JM, Baeten M, et al. Endarterectomy combined with retrograde stenting for tandemlesions of the carotid artery. Acta Chir Belg. 2011 ; 111 (5) : 312-4.
 
7) Starodubtsev V, Karpenko A, Ignatenko P. Hybrid Inter ventions in the Case of Combined Stenosis of theCarotid Bifurcations and Supra-Aortic Arteries. J Stroke Cerebrovasc Dis. 2015 ; pii : S1052-3057 (15) 00478-4. doi : 10.1016/j.jstrokecerebrovasdis.2015.08.034. [Epub ahead of print]
 
8) Sfyroeras GS, Karathanos C, Antoniou GA, et al. A meta-analysis of combined endarterectomy and proximal balloon angioplasty for tandem disease of the arch vessels and carotidbifurcation. J Vasc Surg. 2011 ; 54 (2) : 534-40. doi : 10.1016/j.jvs.2011.04.022. Review.
 
9) Markatis FA, Sfyroeras GS, Moulakakis KG, et al. Endovascular treatment of tandem lesion of the carotid arteries. Ann Vasc Surg. 2014 ; 28 (5) : 1315.e5-9. doi : 10.1016/j.avsg.2013.09.021. Epub 2013 Dec 22.
 
P.359 掲載の参考文献
1) Johansson E, Fox AJ. Carotid near-occlusion : A comprehensive review, part 2-prognosis and treatment, pathophysiology, confusions, and areas for improvement. AJNR Am J Neuroradiol. 2016 ; 37 : 200-4.
PubMed
2) Johansson E, Fox AJ. Carotid near-occlusion : A comprehensive review, part 1-definition, terminology, and diagnosis. AJNR Am J Neuroradiol. 2016 ; 37 : 2-10.
 
3) 日本脳卒中学会 脳卒中ガイドライン委員会編. 脳卒中治療ガイドライン 2015, 協和企画, 2015.
 
4) 岡村耕一, 卯田健, 他. 内頸動脈偽閉塞症 (atheromatous pseudo-occlusion) に対する治療戦略と転帰. 脳外誌. 2008 ; 17 : 857-64.
 
5) Kao HL, Lin MS, et al. Feasibility of endovascular recanalization for symptomatic cervical internal carotid artery occlusion. J Am Coll Cardiol. 2007 ; 49 : 765-71.
PubMed
6) Johansson E, Ohman K, et al. Symptomatic carotid nearocclusion with full collapse might cause a very high risk of stroke. J Intern Med. 2015 ; 277 : 615-23.
 
7) GJ H, CP W. Prognosis of symptomatic carotid artery occlusion. An overview. Cerebrovasc Dis. 1991 ; 1 : 245-56.
 
8) Powers WJ, Clarke WR, et al. Extracranial-intracranial bypass surgery for stroke prevention in hemodynamic cerebral ischemia : The carotid occlusion surgery study randomized trial. JAMA. 2011 ; 306 : 1983-92.
PubMed
9) Powers WJ, Derdeyn CP, et al. Benign prognosis of neversymptomatic carotid occlusion. Neurology. 2000 ; 54 : 878-82.
PubMed
10) Mylonas SN, Antonopoulos CN, et al. Management of patients with internal carotid artery near-total occlusion : An updated meta-analysis. Ann Vasc Surg. 2015 ; 29 : 1664-72.
PubMed
11) Paty PS, Adeniyi JA, et al. Surgical treatment of internal carotid artery occlusion. J Vasc Surg. 2003 ; 37 : 785-8.
PubMed
12) 太田剛史, 中原一郎, 他. 内頚動脈慢性完全閉塞に対する再開通療法-文献レビューと展望. JNET. 2014 ; 8 : 3-13.
Medical*Online
13) Sakamoto S, Kiura Y, et al. Carotid artery stenting using the proximal or dual protection method for near occlusion of the cervical internal carotid artery. Neurosurg Rev. 2013 ; 36 : 551-7 ; discussion 7-8.
 
14) Terada T, Okada H, et al. Endovascular recanalization of the completely occluded internal carotid artery using a flow reversal system at the subacute to chronic stage. J Neurosurg. 2010 ; 112 : 563-71.
 
15) Son S, Choi DS, et al. Carotid artery stenting in patients with near occlusion : A single-center experience and comparison with recent studies. Clin Neurol Neurosurg. 2013 ; 115 : 1976-81.
PubMed
16) Shojima M, Nemoto S, et al. Protected endovascular revascularization of subacute and chronic total occlusion of the internal carotid artery. AJNR Am J Neuroradiol. 2010 ; 31 : 481-6.
PubMed
17) Shih YT, Chen WH, et al. Hybrid surgery for symptomatic chronic total occlusion of carotid artery : A technical note. Neurosurgery. 2013 ; 73 : onsE117-23 ; discussion onsE23.
PubMed
18) Koyanagi M, Yoshida K, et al. Reduced cerebrovascular reserve is associated with an increased risk of postoperative ischemic lesions during carotid artery stenting. J Neurointerv Surg. 2014.
PubMed
P.365 掲載の参考文献
1) Ferguson GG, Eliasziw M, Barr HW, et al. The North American Symptomatic Carotid Endarterectomy Trial : surgical results in 1415 patients. Stroke. 1999 ; 30 (9) : 1751-8.
PubMed
2) Findlay JM, Marchak BE. Reoperation for acute hemispheric stroke after carotid endarterectomy : is there any value? Neurosurgery. 2002 ; 50 (3) : 486-92 ; discussion 492-3.
 
3) Anzuini A, Briguori C, Roubin GS, et al. Emergency stenting to treat neurological complications occurring after carotid endarterectomy. J Am Coll Cardiol. 2001 ; 37 (8) : 2074-9.
PubMed
4) Kim SH, Qureshi AI, Levy EI, et al. Emergency stent placement for symptomatic acute carotid artery occlusion after endarterectomy. Case report. J Neurosurg. 2004 ; 101 (1) : 151-3.
PubMed
5) Spiotta AM, Vargas J, Zuckerman S, et al. Acute stroke after carotid endarterectomy : time for a paradigm shift? Multicenter experience with emergent carotid artery stenting with or without intracranial tandem occlusion thrombectomy. Neurosurgery. 2015 ; 76 (4) : 403-10.
PubMed
6) Ko JK, Choi CH, Lee SW, et al. Emergency placement of stent-graft for symptomatic acute carotid artery occlusion after endarterectomy. J Neurointerv Surg. 2016 ; 8 (3) : e9
PubMed
7) Ross CB, Ranval TJ. Intraoperative use of stents for the management of unacceptable distal internal carotid artery end points during carotid endarterectomy : short-term and midterm results. J Vasc Surg. 2000 ; 32 (3) : 420-7 ; 427-8.
 
8) 石橋良太, 中原一郎. 頸動脈狭窄症 : 不安定プラークに対するCASのデバイス選択. 脳血管内治療レファレンス, 中外医学社, 東京, 2015, p111-8.
 
P.370 掲載の参考文献
1) Carmody BJ, Arora S, et al. Accelerated carotid artery disease after high-dose head and neck radiotherapy : is there a role for routine carotid duplex surveillance? J Vasc Surg. 1999 ; 30 (6) : 1045-51.
 
2) Favre JP, Nourissat A, et al. Endovascular treatment for carotid artery stenosis after neck irradiation. J Vasc Surg. 2008 ; 48 (4) : 852-8.
PubMed
3) Fokkema M, den Hartog AG, et al. Stenting versus surgery in patients with carotid stenosis after previous cervical radiation therapy : systematic review and meta-analysis. Stroke. 2012 ; 43 (3) : 793-801.
PubMed
4) Kashyap VS, Moore WS, et al. Carotid artery repair for radiation-associated atherosclerosis is a safe and durable procedure. J Vasc Surg. 1999 ; 29 (1) : 90-6 ; discussion 97-9.
 
5) Kearney M, Pieczek A, et al. Histopathology of in-stent restenosis in patients with peripheral artery disease. Circulation. 1997 ; 95 (8) : 1998-2002.
PubMed
6) Moritz MW, Higgins RF, et al. Duplex imaging and incidence of carotid radiation injury after high-dose radiotherapy for tumors of the head and neck. Arch Surg (Chicago, Ill : 1960). 1990 ; 125 (9) : 1181-3.
 
7) Rockman CB, Riles TS, et al. The surgical management of carotid artery stenosis in patients with previous neck irradiation. Am J Surg. 1996 ; 172 (2) : 191-5.
PubMed
8) Sano N, Satow T, et al. Relationship between histologic features and outcomes of carotid revascularization for radiation-induced stenosis. J Vasc Surg. 2015 ; 62 (2) : 370-7. e371.
 
9) Setacci C, de Donato G, et al. In-stent restenosis after carotid angioplasty and stenting : a challenge for the vascular surgeon. Eur J Vasc Endovasc Surg. 2005 ; 29 (6) : 601-7.
PubMed
10) Shichita T, Ogata T, et al. Angiographic characteristics of radiation-induced carotid arterial stenosis. Angiology. 2009 ; 60 (3) : 276-82.
PubMed
11) Younis GA, Gupta K, et al. Predictors of carotid stent restenosis. Catheter Cardiovasc Interv. 2007 ; 69 (5) : 673-82.
PubMed
P.376 掲載の参考文献
1) Jovin TG, Gupta R, et al. Emergent stenting of extracranial internal carotid artery occlusion in acute stroke has a high revascularization rate. Stroke. 2005 ; 36 : 2426-30.
 
2) Papanagiotou P, Roth C, et al. Carotid artery stenting in acute stroke. J Am Coll Cardiol. 2011 ; 58 : 2363-9.
PubMed
3) Tsivgoulis G, Krogias C, et al. Safety of early endarterectomy in patients with symptomatic carotid artery stenosis: an international multicenter study. Eur J Neurol 2014 ; 21 (10) : 1251-7.
PubMed
4) Rantner B, Geobel G, et al. Carotid Stenting Trialists Collaboration: The risk of carotid artery stenting compared with carotid endarterectomy is greatest in patients treated within 7 days of symptoms. J Vasc Surg. 2013 ; 57 : 619-26.
 
5) Topakian R, Strasak AM, et al. Timing of stenting of symptomatic carotid stenosis is predictive of 30-day outcome. Eur J Neurol. 2007 ; 14 : 672-8.
PubMed
6) Yoshimura S, Kitajima H, et al. Staged angioplasty for carotid artery stenosis to prevent postoperative hyperperfusion. Neurosurgery. 2009 ; 64 : 122-9.
 
7) Hacke W, Kaste M, et al. ECASS Investigations : Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008 ; 359 : 1317-29.
PubMed
8) Sallustio F, Koch G, et al. Safety of early carotid stenting after systemic thrombolysis : a single center experience. Stroke Res Treat. 2012 ; 10 : 1155-9.
 
9) 久門良明, 渡邉英昭, 他. 頚動脈狭窄に対する発症急性期ないし亜急性期血行再建術の手術成績. 脳循環代謝. 2014 ; 25 : 15-21.
 
10) Moulakakis KG, Mylonas SN, et al. Hyperperfusion after carotid revascularization. J Vasc Surg. 2009 ; 49 : 1060-8.
PubMed
P.383 掲載の参考文献
1) Sakai N, Yamagami H, et al. Prospective registry of carotid artery stenting in Japan-investigation on device and antiplatelet for carotid artery stenting. J Stroke Cerebrovasc Dis. 2014 ; 23 (6) : 1374-84.
PubMed
2) Price MJ, Berger PB, et al. Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary inter vention : the GRAVITAS randomized trial. JAMA. 2011 ; 305 (11) : 1097-105.
 
3) Goh C, Churilov L, et al. Clopidogrel hyper-response and bleeding risk in neurointerventional procedures. AJNR Am J Neuroradiol. 2013 ; 34 (4) : 721-6.
PubMed
4) 宮田茂樹, 山本晴子. ヘパリン起因性血小板減少症 (HIT) の治療. 血栓止血誌. 2008 ; 19 (2) : 195-8.
 
5) Altinbas A, Algra A, et al. Periprocedural hemodynamic depression is associated with a higher number of new ischemic brain lesions after stenting in the International Carotid Stenting Study-MRI Substudy. Stroke. 2014 ; 45 (1) : 146-51.
PubMed
6) Wu TY, Ham SW, et al. Predictors and consequences of hemodynamic instability after carotid artery stenting. Ann Vasc Surg. 2015 ; 29 (6) : 1281-5.
PubMed
7) Ullery BW, Nathan DP, et al. Incidence, predictors, and outcomes of hemodynamic instability following carotid angioplasty and stenting. J Vasc Surg. 2013 ; 58 (4) : 917-25.
PubMed
8) Zheng J, Liu L, et al. Carotid endarterectomy with stent removal in management of in-stent restenosis : a safe, feasible, and effective technique. Eur J Vasc Endovasc Surg. 2014 ; 47 (1) : 8-12.
 
9) Sato M, Matsumaru Y, et al. Detailed analysis of puncture site vascular complications in Japanese Registry of Neuroendovascular Therapy (JR-NET) and JR-NET2. Neurol Med Chir (Tokyo). 2014 ; 54 (1) : 17-22.
 
P.388 掲載の参考文献
1) Ogasawara K, Sakai N, et al. lntracranial hemorrhage associated with cerebral hyperper fusion syndrome following carotid endarterectomy and carotid artery stenting : retrospective review of 4494 patients. J Neurosurg. 2007 ; 107 : 1130-6.
 
2) Kawamata T, Okada Y, et al. Postcarotid endarterectomy cerebral hyperperfusion can be prevented by minimizing intraoperative cerebral ischemia and strict postoperative blood pressure control under continuous sedation. Neurosurgery. 2009 ; 64 : 447-53 ; discussion 453-4.
 
3) Ogasawara K, Inoue T, et al. Pretreatment with the free radical scavenger edaravone prevents cer ebral hyperperfusion after carotid endarterectomy. Neurosurgery. 2004 ; 55 (5) : 1060-7.
 
4) Kaku Y, Yoshimura S, et al. Factors predictive of cerebral hyperper fusion after carotid angioplasty and stent placement. AJNR Am J Neuroradiol. 2004 ; 25 : 1403-8.
 
5) Yoshimura S, Kitajima H, et al. Staged angioplasty for carotid artery stenosis to prevent postoperative hyperperfusion. Neurosurgery. 200 ; 964 (suppl 3) : ons122-8 ; discussion ons 128-9.
 
6) Uchida K, Yoshimura S, et al. Experience of Staged Angioplasty to Avoid Hyperperfusion Syndrome for Carotid Artery Stenosis. Neurol Med Chir (Tokyo). 2015 ; 16 ; 55 (11) : 824-9.
 
7) Yoshimura S, Yamada K, et al. High-intensity signal on time-of-flight magnetic resonance angiography indicates carotid plaques at high risk for cerebral embolism during stenting. Stroke. 2011 ; 42 (11) : 3132-7.
PubMed
P.395 掲載の参考文献
1) 桑山直也, 他. 本邦における頸動脈治療の前向き登録 (JCAS研究). J Jpn Coll Angiol. 2010 ; 50 : 723-7.
 
2) Bonati LH, et al. Long-term risk of carotid restenosis in patients randomly assigned to endovascular treatment or endarterectomy in the Carotid and Ver tebral Artery Transluminal Angioplasty Study (CAVATAS) : long-term follow-up of a randomized trial. Lancet Neurol. 2009 ; 8 : 908-17.
PubMed
3) Gurm HS, et al. Long-Term Results of Carotid Stenting versus Endarterectomy in High-Risk Patients. N Engl J Med. 2008 ; 358 : 1572-9.
PubMed
4) Eckstein HH, et al. Results of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years : a multinational, prospective, randomised trial. Lancet Neurol. 2008 ; 7 : 893-902.
 
5) Arquizan C, et al. Restenosis Is More Frequent After Carotid Stenting Than After Endarterectomy : The EVA-3S Study. Stroke. 2011 ; 42 : 1015-20.
PubMed
6) Lal BK, et al. Restenosis after carotid artery stenting and endarterectomy : a secondary analysis of CREST, a randomised controlled trial. Lancet Neurol. 2012 ; 11 : 755-63.
 
7) 原田啓, 他. 頭頸部主幹動脈ステント留置術後のヘリカルCTによる評価-血管造影所見との比較検討. No Shinkei Geka. 2004 ; 32 : 29-35.
 
8) Beach KW, et al. Standardized ultrasound evaluation of carotid stenosis for clinical trailas : University of Washington Ultrasound Reading Center. Cardiovasc Ultrasound. 2010 ; 8 : 39.
PubMed
9) Koga M, et al. Diagnosis of Internal Carotid Artery Stenosis Greater than 70 % with Power Doppler Duplex Sonography. AJNR Am J Neuroradiol. 2001 ; 22 : 413-7.
PubMed
10) 阪井田博司. 再狭窄. 滝和郎編. 頚動脈ステント留置術ハンドブック. 診断と治療社, 東京, 2009, p116-20.
 
11) Toma N, et al. Histopathological findings in a human carotid artery after stent implantation-Case report. J Neurosurg. 2003 ; 98 : 199-204.
 
12) Tsutsumi M, et al. Angiographically confirmed stent over expression in the internal carotid artery during stenting : incidence, predictors, and outcomes. Neuroradiology. 2012 ; 54 : 481-6.
 
13) Kimura T, et al. Long-Term Clinical and Angiographic Follow-Up After Coronary Stent Placement in Native Coronary Arteries. Circulation. 2002 ; 105 : 2986-91.
PubMed
14) Takami H, et al. Spontaneous regression of restenosis after CEA : significance of preoperative plaque characteristics under duplex ultrasound ; clinical investigation. Acta Neurochir. 2014 ; 156 : 63-7.
PubMed
15) Kernan WN, et al. Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2014 ; 45 : 2160-36.
PubMed
16) Healy DA, et al. Long-term follow-up and clinical outcome of carotid restenosis. J Vasc Surg. 1989 ; 10 : 662-8.
PubMed
17) Brott TG, et al. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease : Executive Summary. Stroke. 2011 ; 42 : e420-63.
PubMed
18) 宮田悠, 他. 頚動脈ステント留置術後再狭窄の同側脳梗塞発症リスクと予測因子. JNET. 2015 ; 9 : 245-53.
Medical*Online
P.399 掲載の参考文献
1) Cremonesi A, et al. Carotid artery stenting : an update. Eur Heart J. 2015 ; 36 : 13-21.
PubMed
2) Kedev S, et al. Safety of slender 5 Fr transradial approach for carotid artery stenting with a novel nitinol double-layer micromesh stent. Am J Cardiol. 2015 ; 116 : 977-81.
 
3) Hopf-Jensen S, et al. Initial clinical experience with the micromesh RoadSaver carotid artery stent for the treatment of patients with symptomatic carotid artery disease. J Endovasc Ther. 2015 ; 22 : 220-5.
PubMed
4) Wissgott C, et al. Preliminary clinical results and mechanical behavior of a new double-layer carotid Stent. J Endovasc Ther. 2015 ; 22 : 634-9.
 
5) Shindo S, et al. Three-dimensional optical frequency domain imaging evaluation of novel dual-layered carotid stent implantation for vulnerable carotid plaque. J Stroke Cerebrovasc Dis. 2016 ; 25 : e31-2.
PubMed
6) Castagno C, et al. Preoperative and postoperative evaluation of new double mesh carotid stents with contrast-enhanced ultrasound and diffusion-weighted imaging. Ann Vasc Surg. 2016 ; 33 : 228e9-13.
PubMed
7) Bosiers M, et al. The CLEAR-ROAD study : evaluation of a new dual layer micromesh stent system for the carotid artery. Eurointervention. 2016 ; 12 : e672-6.
 
8) Nerla R, et al. Carotid artery stenting with a new-generation double-mesh stent in three high-volume Italian centres : clinical results of a multidisciplinary approach. Eurointervention. 2016 ; 12 : e677-83.
PubMed
9) Shoefer J, et al. A prospective, multicenter study of a novel mesh-covered carotid stent. The CGuard CARENET Trial. JACC Cardiovasc Interv. 2015 ; 8 : 1229-34.
 
10) Musialek P, et al. Novel PARADIGM in carotid revascularisation : Prospective evaluation of All-comer percutaneous carotid revascularisation in symptomatic and increased-risk asymptomatic carotid artery stenosis using CGuard(TM) MicroNet-covered embolic prevention stent system. Eurointervention. 2016 ; epub ahead of print.
 
11) Schonholz C, et al. First-in-man implantation of a new hybrid carotid stent to prevent periprocedural neurological events during carotid artery stenting. J Endovasc Ther. 2014 ; 21 : 601-4.
PubMed

V 外科的治療 (3) : 頚動脈狭窄症と複合血管治療

P.411 掲載の参考文献
1) Brott TG, Hobson RW, 2 nd, et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010 ; 363 : 11-23.
 
2) Fandino J, Taussky P, et al. The concept of a hybrid operating room : applications in cerebrovascular surgery. Acta Neurochir Suppl. 2013 ; 115 : 113-7.
PubMed
3) Iihara K, Satow T, et al. Hybrid operating room for the treatment of complex neurovascular and brachiocephalic lesions. J Stroke Cerebrovasc Dis. 2013 ; 22 : e277-85.
PubMed
4) Mori R, Joki T, et al. Initial experience of real-time intraoperative C-arm computed-tomography-guided navigation surgery for pituitary tumors. World Neurosurg. 2013 ; 79 : 319-26.
PubMed
5) Goldstein LB, McCrory DC, et al. Multicenter review of preoperative risk factors for carotid endarterectomy in patients with ipsilateral symptoms. Stroke. 1994 ; 25 : 1116-21.
PubMed
6) Rothwell PM, Eliasziw M, et al. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet. 2003 ; 361 : 107-16.
PubMed
7) Ogata T, Yasaka M, et al. Outcomes associated with carotid pseudo-occlusion. Cerebrovasc Dis. 2011 ; 31 : 494-8.
PubMed
8) Greiner C, Wassmann H, et al. Revascularization procedures in internal carotid artery pseudo-occlusion. Acta Neurochir (Wien). 2004 ; 146 : 237-43 ; discussion 243.
PubMed
P.419 掲載の参考文献
1) Klonaris C, Kouvelos GN, et al. Common carotid artery occlusion treatment : revealing a gap in the current guidelines. Eur J Vasc Endovasc Surg. 2013 ; 46 : 291-8.
PubMed
2) Dermitzakis I, Minardos I, et al. Color duplex sonography of occlusion of the common carotid artery with reversed flow in the extracranial internal carotid artery. J Clin Ultrasound. 2002 ; 30 : 388-91.
PubMed
3) Levine SR, Welch KM. Common carotid artery occlusion. Neurology. 1989 ; 39 : 178-86.
PubMed
4) Cull DL, Hansen JC, et al. Internal carotid artery patency following common carotid artery occlusion : management of the asymptomatic patient. Ann Vasc Surg. 1999 ; 13 : 73-6.
PubMed
5) 岡田芳和, 米山琢, 他. 大血管バイパス術. 新NS NOW 1 バイパス術のすべて, メジカルビュー社, 東京, 2015, p108-15.
 
6) Fry WR, Mar tin JD, et al. Extrathoracic car otid reconstruction : the subclavian-carotid artery bypass. J Vasc Surg. 1992 ; 15 : 83-8.
 
7) Archie JP Jr. Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease. J Vasc Surg. 1999 ; 30 : 1106-12.
 
8) Mason JC. Takayasu arteritis : surgical interventions. Curr Opin Rheumatol. 2015 ; 27 : 45-52.
PubMed
9) Paukovits TM, Haasz J, et al. Transfemoral endovascular treatment of proximal common carotid artery lesions : a single-center experience on 153 lesions. J Vasc Surg. 2008 ; 48 : 80-7.
PubMed
10) Welleweerd JC, den Ruijter HM, et al. Management of extracranial carotid artery aneurysm. Eur J Vasc Endovasc Surg. 2015 ; 50 : 141-7.
PubMed
11) Yoneyama T, Kawashima A, et al. Technical options for the surgical management of extracranial carotid artery aneurysms. Three case reports. Neurol Med Chir (Tokyo). 2012 ; 52 : 208-12.
PubMed
P.425 掲載の参考文献
1) Endo S, Kuwayama N, et al. Japan Carotid Atherosclerosis Study : JCAS. Neurol Med Chir (Tokyo). 2004 ; 44 : 215-7.
PubMed
2) Tanimoto S, Ikari Y, et al. Prevalence of carotid artery stenosis in patients with coronary artery disease in Japanese population. Stroke. 2005 ; 36 : 2094-8.
PubMed
3) Yadav JS, Wholey MH, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004 ; 351 : 1493-501.
PubMed
4) Stockard JJ, Bickford RG, et al. Hypotension-induced changes in cerebral function during cardiac surgery. Stroke. 1974 ; 5 : 730-46.
PubMed
5) Sedrakyan A, Wu AW, et al. Off-pump surgery is associated with reduced occurence of stroke and other morbidity as compared with traditional coronary artery bypass grafting : a meta-analysis of systemactically reviewed trials. Stroke. 2006 ; 37 : 2759-69.
 
P.429 掲載の参考文献
1) Ogata T, Inoue T, et al. Outcome of 312 Japanese patients with carotid endarterectomy and factors associated with cardiovascular events-a single-center study in Japan. J Stroke Cerebrovasc Dis. 2014 ; 23 (3) : 529-33.
PubMed
2) Razzouk L, Rockman CB, et al. Co-existence of vascular disease in different arterial beds : Peripheral artery disease and carotid artery stenosis- Data from Life Line ScreeningR. Atherosclerosis. 2015 ; 241 (2) : 687-91.
PubMed
3) Yamazaki T, Goto S, et al. Prevalence, awareness and treatment of cardiovascular risk factors in patients at high risk of atherothrombosis in Japan. Circ J. 2007 ; 71 (7) : 995-1003.
PubMed
4) Bhatt DL, Eagle KA, et al. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. JAMA. 2010 ; 304 (12) : 1350-7.
 
5) Boulanger M, Cameliere L, et al. Periprocedural myocardial infarction after carotid endarterectomy and stenting : systematic review and meta-analysis. Stroke. 2015 ; 46 (10) : 2843-8.
PubMed
6) Rantner B, Goebel G, et al. The risk of carotid artery stenting compared with carotid endarterectomy is greatest in patients treated within 7 days of symptoms. J Vasc Surg. 2013 ; 57 (3) : 619-26.
PubMed
7) Meschia JF, Hopkins LN, et al. Time from symptoms to carotid endarterectomy or stenting and perioperative risk. Stroke. 2015 ; 46 (12) : 3540-2.
 
8) 高下純平, 中原一郎, 他. バルーン付きガイディングカテーテルを用いた経上腕動脈アプローチによるproximal balloon protection下の頚動脈ステント留置術 : 9 Fr Optimoを用いたシースレス法. JNET. 2015 ; 9 : 108-14.
Medical*Online
P.436 掲載の参考文献
1) Tunick PA, Kronzon I. Protruding atherosclerotic plaque in the aortic arch of patients with systemic embolization : a new finding seen by transesophageal echocardiography. Am Heart J. 1990 ; 120 (3) : 658-60.
PubMed
2) Amarenco P, Cohen A, et al. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med. 1994 ; 331 (22) : 1474-9.
PubMed
3) 北園孝, 鴨打正, 他. 多施設共同脳卒中データベース (Fukuoka Stroke Registry ; FSR) から見えてきた脳梗塞急性期の病態と予後. 脳卒中. 2010 ; 32 (6) : 566-71.
Medical*Online
4) Toyoda K, Yasaka M, et al. Aortogenic embolic stroke : a transesophageal echocardiographic approach. Stroke. 1992 ; 23 (8) : 1056-61.
PubMed
5) Fujimoto S, Yasaka M, et al. Aortic arch atherosclerotic lesions and the recurrence of ischemic stroke. Stroke. 2004 ; 35 (6) : 1426-9.
PubMed
6) Ueno Y, Kimura K, et al. Mobile aortic plaques are a cause of multiple brain infarcts seen on dif fusion-weighted imaging. Stroke. 2007 ; 38 (9) : 2470-6.
 
7) Faggioli GL, Ferri M, et al. Aortic arch anomalies are associated with increased risk of neurological events in carotid stent procedures. Eur J Vasc Endovasc Surg. 2007 ; 33 (4) : 436-41.
PubMed
8) Jones EF, Kalman JM, et al. Proximal aortic atheroma. An independent risk factor for cerebral ischemia. Stroke. 1995 ; 26 (2) : 218-24.
PubMed
9) Di Tullio MR, Sacco RL, et al. Aortic atheromas and acute ischemic stroke : a transesophageal echocardiographic study in an ethnically mixed population. Neurology. 1996 ; 46 (6) : 1560-6.
 
10) Kronzon I, Tunick PA. Aortic atherosclerotic disease and stroke. Circulation. 2006 ; 114 (1) : 63-75.
PubMed
11) Zavala JA, Amarrenco P, et al. Aortic arch atheroma. Int J Stroke. 2006 ; 1 (2) : 74-80.
PubMed
12) Ueno Y, Yamashiro K, et al. Rosuvastatin may stabilize atheroscler o t i c aort i c plaque : transesophageal echocardiographic study in the EPISTEME trial. Atherosclerosis. 2015 ; 239 (2) : 476-82.
 
13) Amarenco P, Davis S, et al. Clopidogrel plus aspirin versus warfarin in patients with stroke and aortic arch plaques. Stroke. 2014 ; 45 (5) : 1248-57.
PubMed
14) Ferrari E, Vidal R, et al. Atherosclerosis of the thoracic aorta and aortic debris as a marker of poor prognosis : benefit of oral anticoagulants. J Am Coll Cardiol. 1999 ; 33 (5) : 1317-22.
PubMed
15) Choi HM, Hobson RW, et al. Technical challenges in a program of carotid artery stenting. J Vasc Surg. 2004 ; 40 (4) : 746-51 ; discussion 51.
 
16) Lin SC, Trocciola SM, et al. Analysis of anatomic factors and age in patients undergoing carotid angioplasty and stenting. Ann Vasc Surg. 2005 ; 19 (6) : 798-804.
 
17) Fanous AA, Natarajan SK, et al. High-Risk Factors in Symptomatic Patients Undergoing Carotid Artery Stenting With Distal Protection : Buffalo Risk Assessment Scale (BRASS). Neurosurgery. 2015 ; 77 (4) : 531-42 ; discussion 42-3.
 
18) Karanjia PN, Madden KP, et al. Coexistence of abdominal aortic aneurysm in patients with carotid stenosis. Stroke. 1994 ; 25 (3) : 627-30.
PubMed
19) Kang SS, Littooy FN, et al. Higher prevalence of abdominal aortic aneurysms in patients with carotid stenosis but without diabetes. Surgery. 1999 ; 126 (4) : 687-91 ; discussion 91-2.
 
20) Vranes M, Davidovic L, et al. Coexistence of internal carotid artery stenosis in patients with abdominal aortic aneurysm. Korean Circ J. 2013 ; 43 (8) : 550-6.
PubMed
21) Layton KF, Kallmes DF, et al. Bovine aortic arch variant in humans : clarification of a common misnomer. AJNR Am J Neuroradiol. 2006 ; 27 (7) : 1541-2.
PubMed
22) Ogino H, Matsuda H, et al. Overview of late outcome of medical and surgical treatment for Takayasu ar teritis. Circulation. 2008 ; 118 (25) : 2738-47.
 
23) Kim HJ, Lee CS, et al. Outcomes after endovascular treatment of symptomatic patients with Takayasu's arteritis. Interv Neuroradiol. 2011 ; 17 (2) : 252-60.
PubMed
24) Takahashi JC, Sakai N, et al. Multiple supra-aortic stenting for Takayasu arteritis : extensive revascularization and twoyear follow-up. AJNR Am J Neuroradiol. 2002 ; 23 (5) : 790-3.
PubMed

VI わたしの治療戦略

P.441 掲載の参考文献
1) Hirata Y, Sakata N, Inoue T, et al. Histopathological features with angiographic correlates of internal carotid artery pseudo-occlusion : impact of plaque compositions. J Neurosurgery. 2011 ; 115 : 350-8.
 
2) Terada T, Tsuura M, Matsumoto H, et al. Endovascular treatment for pseudo-occlusion of the internal carotid artery. Neurosurgery. 2006 ; 59 : 301-9.
PubMed
3) Kishikawa K, Kamouchi M, Okada Y, et al. Evaluation of distal extracranial internal carotid artery by transoral carotid ultrasonography in patients with severe carotid stenosis. AJNR Am J Neuroradiol. 2002 ; 23 : 924-8.
PubMed
4) 岡村耕一, 卯田健, 井上亨, 他. 内頚動脈偽閉塞症 (Atheromatous Pseudo-Occlusion) に対する治療戦略と転帰. 脳外誌. 2008 ; 17 : 857-64.
 
5) Kawaguchi S, Okuno S, Sasaki T, et al. Effect of carotid endarterectomy on chronic ocular ischemic syndrome due to internal carotid artery stenosis. Neurosurgery. 2001 ; 48 : 328-32.
 
6) Kawaguchi S, Sasaki T, Iwahashi H, et al. Effect of carotid artery stenting on ocular circulation and chronic ocular ischemic syndrome. Cerebrovasc Dis. 2006 ; 22 : 402-8.
 
7) Katsuta T, Fujimoto A, Oba K. Deterioration of glaucoma after carotid endarterectomy. Neurol Med Chir (Tokyo). 2013 ; 53 : 418-21.
PubMed
P.447 掲載の参考文献
1) Bonati LH, Jongen LM, Haller S, et al. New ischaemic brain lesions on MRI after stenting or endarterectomy for symptomatic carotid stenosis : a substudy of the International Carotid Stenting Study (ICSS). Lancet Neurol. 2010 ; 9 : 35-62.
 
2) Gensicke H, van der Worp HB, Nederkoorn PJ, et al. Ischemic brain lesions after carotid artery stenting increase future cerebrovascular risk. J Am Coll Cardiol. 2015 ; 65 : 521-29.
 
3) Maruyama D, Fukuda K, Kataoka H, et al. Evaluation of carotid artery outward remodeling by T1-weighted magnetic resonance imaging in carotid endarterectomy and stenting. J Vasc Surg. 2015 ; 61 : 1464-71.
PubMed
4) Iihara K, Murao K, Sakai N, et al. Outcome of carotid endarterectomy and stent insertion based on grading of carotid endarterectomy risk : a 7-year prospective study. J Neurosurg. 2006 ; 105 : 546-54.
 
5) Sano N, Satow T, Maruyama D, et al. Relationship between histologic features and outcomes of carotid revascularization for radiation-induced stenosis. J Vasc Surg. 2015 ; 62 : 370-7.
PubMed
6) 日本脳卒中学会 脳卒中ガイドライン委員会. 脳卒中治療ガイドライン 2015. 東京, 協和企画, 2015.
 
7) Bond R, Rerkasem K, Rothwell PM. Systematic review of the risks of carotid endarterectomy in relation to the clinical indication for and timing of surgery. Stroke. 2003 ; 34 : 2290-301.
 
P.453 掲載の参考文献
1) 日本脳卒中学会 脳卒中ガイドライン委員会編. 3 脳梗塞慢性期, 3-8 頚動脈内膜剥離術, 3-9 経皮的血管形成術と頚動脈ステント留置術. 脳卒中治療ガイドライン 2015, 協和企画, 東京, 2015, p127-32.
 
2) Abbott AL. Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis. Results of a systemic review and analysis. Stroke. 2009 ; 40 : 573-83.
 
P.457 掲載の参考文献
1) Yadav JS, Wholey MH, Kuntz RE, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004 ; 351 : 1493-501.
PubMed
2) Mas JL, Chatellier G, Beyssen B, et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med. 2006 ; 355 : 1660-71.
PubMed
3) The SPACE Collaborative Group. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients : a randomized non-inferiority trial Lancet 2006 ; 368 : 1239-47.
 
4) Bonati LH, Dobson J, Featherstone RL, et al. Long-term outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis : the International Carotid Stenting Study (ICSS) randomised trial. Lancet. 2015 ; 385 : 529-38.
PubMed
5) Brott TG, Hobson RW II, Howard G, et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010 ; 363 : 11-23.
 
6) Rosenfield K, Naksynyra JS, Chatur vedi S, et al. Randomized trial of stent versus surgery for asymptomatic carotid stenosis. N Engl J Med. 2016 ; 374 : 1011-20.
 
7) 柏木淳之, 清末一路, 中原一郎, 他. Angioguard XPを用いた頸動脈ステント留置術中塞栓性合併症に関する多施設共同研究-MR plaque imageと狭窄長によるハイリスク群の抽出-. JNET. 2008 ; 2 : 179-87.
Medical*Online
8) Matsumoto S, Nakahara I, Higashi T, et al. Fibro-fatty volume of culprit lesions in virtual histology(TM) intravascular ultrasound is associated with the amount of debris during carotid artery stenting. Cerebrovasc Dis. 2010 ; 29 : 468-75.
 
9) Miyachi S, Taki W, Sakai N, et al. Historical perspective of carotid artery stenting in Japan : analysis of 8,092 cases in the Japanese CAS survey. Acta Neurochir (Wien) 2012 ; 154 : 2127-37.
PubMed
10) 石橋良太, 太田剛史, 中原一郎. 頚動脈ステント留置術の基本. Jpn J Intervent Radiol. 2013 ; 28 : 28-36.
 
11) Matsumoto S, Nakahara I, Higashi T, et al. Near-infrared spectroscopy in carotid artery stenting predicts cerebral hyperperfusion syndrome. Neurology. 2009 ; 72 : 1512-8.
PubMed
12) 橋本哲也, 中原一郎, 太田剛史, 他. 過灌流流症候群ハイリスク症例に対するstaged CASの限界 : 二期的治療を断念した2例. 日本血管内治療学会誌. 2013 ; 14 : 21-4.
 
13) 宮田悠, 中原一郎, 太田剛史, 他. 症候性頚動脈高度狭窄症に対しlow flow bypassを先行することで頚動脈内膜剥離術後の過灌流症候群を回避できた1例. Jpn J Neurosurg (Tokyo). 2015 ; 24 : 48-53.
 
14) 宮田悠, 中原一郎, 石井暁, 他. 頚動脈ステント留置術後再狭窄の同側脳梗塞発症リスクと予測因子. JNET. 2015 ; 9 : 245-53.
Medical*Online
15) 中原一郎, 永田 泉. 頚動脈内膜剥離術. Modern Physician. 2015 ; 35 : 629-36.
 
P.463 掲載の参考文献
1) 日本脳神経外科学会資料 : CEAとCASの手術件数の年次推移. 2015.
 
2) Hobson RW, et al. Carotid artery stenting is associated with increased complications in octogenarians : 30-day stroke and death rates in the CREST lead-in phase. J Vasc Surg. 2004 ; 40 : 1106-11.
PubMed
3) Brott TG, Hobson RW II, Howard G, et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010 ; 363 : 11-23.
 
4) Voeks JH, et al. Age and outcomes after carotid stenting and endarterectomy : the carotid revascularization endarterectomy versus stenting trial. Stroke. 2011 ; 42 : 3484-90.
PubMed
5) Carotid stenting trialists's collaboration. Short-term outcome after stenting versus endarterectomy for symptomatic carotid stenosis : a preplanned meta-analysis of individual patient data. Lancet. 2010 ; 376 : 1062-73.
 
6) Voeks JH, Howard G, Roubin G, et al. Mediators of the age effect in the carotid revascularization endarterectomy versus stenting trial (CREST). Stroke. 2015 ; 46 : 2868-73.
PubMed
7) Macdonald S, Lee R, Williams R, et al. Towards safer carotid artery stenting : A scoring system for anatomic suitability. Stroke. 2009 ; 40 : 1698-703.
PubMed
8) Werner M, et al. anatomic variables contributing to a higher periprocedural incidence of stroke and TIA in carotid artery stenting : Single Center Experience of 833 Consecutive Cases. Catheter Cardiovasc Interv. 2012 ; 80 : 321-8.
PubMed
9) Paola De Rango, Martin M Brown, Seemant Chaturvedi, et al. Summary of Evidence on Early Carotid Intervention for Recently Symptomatic Stenosis Based on Meta-Analysis of Current Risks. Stroke. 2015 ; 46 : 3423-36.
PubMed
10) 松本典子, 木村和美, 松原俊二, 他. 超音波造影剤を用いた造影頚部血管エコーによるステント内血栓症評価の試み. Neurosonology. 2014 ; 26 (3), 135
 

VII 頚動脈狭窄症のガイドライン・治療指針

P.474 掲載の参考文献
1) Graham R, Mancher M, et al. Clinical practice guidelines we can trust. National Academies Press, Washington DC, 2011.
 
2) Abbott AL, Paraskevas KI, et al. Systematic review of guidelines for the management of asymptomatic and symptomatic carotid stenosis. Stroke. 2015 ; 46 : 3288-301.
PubMed
3) Ricotta JJ, Aburahma A, et al. Updated society for vascular surgery guidelines for management of extracranial carotid disease : Executive summary. J Vasc Surg. 2011 ; 54 : 832-6.
 
4) Bushnell C, McCullough LD, et al. Guidelines for the prevention of stroke in women : A statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2014 ; 45 : 1545-88.
PubMed
5) Lindsay MP, Gubitz G, et al. Canadian best practice recommendations for stroke care. Canadian Stroke Network, Canada, 2010.
 
6) Royal Australian College of General Practitioners. Prevention of vascular and metabolic disease. Guidelines for preventive activities in general practice, 8 th ed, Australia, 2012.
PubMed
7) National Collaborating Centre for Chronic Conditions. Stroke. Diagnosis and initial management of acute stroke and transient ischaemic attack (tia). National Institute for Health and Clinical Excellence (NICE), United Kingdom, 2011.
 
8) European Stroke Organisation Executive Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack. Cerebrovasc Dis. 2008 ; 25 : 457-507.
PubMed
9) Jauch EC, Saver JL, et al. Guidelines for the early management of patients with acute ischemic stroke : A guideline for healthcare professionals from the american heart association/american stroke association. Stroke. 2013 ; 44 : 870-947.
PubMed
10) Kernan WN, Ovbiagele B, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack : A guideline for healthcare professionals from the american heart association/american stroke association. Stroke. 2014 ; 45 : 2160-236.
PubMed
11) Powers WJ, Derdeyn CP, et al. 2015 american heart association/american stroke association focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment : A guideline for healthcare professionals from the american heart association/american stroke association. Stroke. 2015 ; 46 : 3020-35.
PubMed
12) Meschia JF, Bushnell C, et al. Guidelines for the primary prevention of stroke : A statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2014 ; 45 : 3754-832.
PubMed
13) LeFevre ML, Force USPST. Screening for asymptomatic carotid artery stenosis : U. S. Preventive services task force recommendation statement. Ann Intern Med. 2014 ; 161 : 356-62.
 
14) Lim LS, Haq N, et al. Atherosclerotic cardiovascular disease screening in adults : American college of preventive medicine position statement on preventive practice. Am J Prev Med. 2011 ; 40 : 381 e1-10.
 
15) Singapore Ministry of Health. Screening for cardiovascular disease and risk factors, Singapore, 2011.
PubMed
16) National Stroke Foundation. Secondary prevention. Clinical guidelines for stroke management, Australia, 2010.
PubMed
17) Irimia P, Asenbaum S, et al. Use of imaging in cerebrovascular disease. European handbook of neurological management. 2 nd ed, EU, 2011.
 
18) University of Michigan Health System. Secondary prevention of ischemic heart disease and stroke in adults, Michigan, 2014.
 
19) De La Paz RL, Wippold FJ II, et al. Acr appropriateness criteria(R) cerebrovascular disease. J Am Coll Radiol. 2011 ; 8 : 532-8.
 
20) Adams HP, Jr, Bendixen BH, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Toast. Trial of org 10172 in acute stroke treatment. Stroke. 1993 ; 24 : 35-41.
 
21) Biller J, Feinberg WM, et al. Guidelines for carotid endarterectomy : A statement for healthcare professionals from a special writing group of the stroke council, american heart association. Circulation. 1998 ; 97 : 501-9.
PubMed
22) Bettmann MA, Katzen BT, et al. Carotid stenting and angioplasty : A statement for healthcare professionals from the councils on cardiovascular radiology, stroke, cardiothoracic and vascular surger y, epidemiology, and prevention, and clinical cardiology, american heart association. Circulation. 1998 ; 97 : 121-3.
 
23) 日本脳卒中学会 脳卒中ガイドライン委員会編. 脳卒中治療ガイドライン 2015, 協和企画, 東京, 2015.
 
24) 日本脳ドック学会 脳ドックの新ガイドライン作成委員会編. 脳ドックのガイドライン 2014, 日本, 2014.
 
25) Miyachi S, Taki W, et al. Historical perspective of carotid artery stenting in japan : Analysis of 8,092 cases in the japanese cas survey. Acta Neurochir (Wien). 2012 ; 154 : 2127-37.
PubMed
26) Pronovost PJ. Enhancing physicians' use of clinical guidelines. JAMA. 2013 ; 310 : 2501-2.
PubMed

書評

最近チェックした商品履歴

Loading...